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ABstract of thesis entitled: 
GENE EXPRESSION PROFILING DURING THE 
DEVELOPMENT OF TESTICULAR HYPERTROPHY IN 
NEONATAL HYPOTHYROID RATS 
submitted by TAO Kin-pong, Department of Physiology, 
for the degree of Master of Philosophy at The Chinese University of Hong Kong 
Abstract 
Spermatogenesis is a well coordinated process which involves complex 
interactions between Sertoli cells and developing spermatogonia. During the 
migration of germ cells from basal side to adluminal compartment of seminiferous 
tubule, extracellular matrix and intracellular cytoskeleton were under a continuous 
dynamics with constant assembly and disassembly of structural and adhesion 
molecules. While maintaining an adhesive force is essential to keep differentiating 
cells attaching onto the Sertoli cell lining, a degree of slack is also needed to allow 
pushing the matured sperm across the epithelium. These two counteracting actions 
must be adjusted in a fine manner, yet the molecular mechanism is still an unanswered 
paradox. Proteases, protease inhibitors and matrix molecules could be crucial factors 
controlling the normal development of mammalian testis. 
Transient neonatal hypothyroidism is known to result in a paradoxical 
enlargement of adult testis by extending the proliferation periods of Sertoli cells. In 
this study, hypothyroidism was induced by giving 0.1% propylthiouracil (PTU) in 
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rats' drinking water between postnatal Day 4 to 24. Transcriptional profiles of 
proteases and protease inhibitors, especially the family of An Disintegrin and 
Metalloproteases (ADAMs) and Tissue Inhibitors of Metalloproteases (TIMPs), were 
examined extensively by using Real-Time RT-PCR. Cytokines, matrix adhesion 
proteins and small GTPases genes were also examined. Temporal gene expressions of 
PTU-treated litters were compared with that of control at postnatal day 24，30，40, 50, 
60 and 90 aged testes. Result showed that hypothyroid rats suffered a significant 
down-regulation of most studied genes before day 40 or day 50, but all recovered 
back to normal level afterwards. Gene expressions under different treatment regimens 
by changing the concentration and duration of goitrogen administration have also 
examined. 
Data obtained from this model of testicular hypertrophy share extreme coherence 
with the gene clustering data generated from a recent micro-array study on the 
developmental regulation of testicular genes. Genes that were classified as 
"MEIOTIC" cluster (ADAM2, 3A, 5, Sert-1, Pki (3 etc) all suffered severe 
down-regulation under hypothyroidism before day 40，while genes that extended this 
down-regulation up to postnatal day 50 were categorized into "POST-MEIOTIC" 
(ADAM 4，6 ACE, Cystatin 8，etc). Interestingly, genes like Col3al，Id-2, GATA-4 
and many GTPases which were grouped as "MITOTIC" cluster do not show any 
unique temporal expression pattern. Lastly, transcription of "SOMATIC" genes are 
always not time or treatment dependent. Specific expression patterns drew from this 
clustering idea proved that particular types of genes within same cluster should have 
their own critical period of action. Profiling of transcriptome may help to predicate 
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ajMG Alpha-2 Macroglobulin 
3(3-HSD 3 beta-hydroxysteroid dehydrogenase 
ABP Androgen Binding Protein 
ACE Angiotensin Converting Enzyme 
Act Activator of CREM in testis 
ADAM A Disintegrin and Metalloprotease 
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AN OVA Analysis of Variance 
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CREM Cyclic AMP response element modulator 
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Eppin Serine protease inhibitor-like, with Kunitz and WAP domain 1 
ER Endoplasmic reticulum 
FSH Follicle Stimulating Hormone 
GATA-4 Zinc finger proteins that bind to A/T GATA A/G consensus sequence -4 
GnRH Gonadotrophin Releasing Hormone 
GTPase Guanosine Triphosphatase 
Id Inhibition of differentiation proteins 
Kip1 Cyclic-dependent kinase inhibitor with Mr of 21kDa 
KRP Kinesin-related Protein 







Lhf- Luteinizing Hormone 
MGP Matrix Gla Protein 
MMI Methimazole 
MMPs Matrix Metalloproteases 
MT-MMP Membrane Type - Metalloprotease 
Nedd4a Neural precursor cell expressed, developmentally down-regulated gene 4a 
Nep Neprilysin 
NT3 Neurotrophin 3 
〇df Outer dense fibre protein 
PAs Plasminogen Activators 
PACAP38 Pituitary Adenylate Cyclase Activating Polypeptide 1 (Adcyapl) 
PACAPr Adenylate cyclase activating polypeptide 1 receptor 1 (Adcyapl l i ) 
PAI Plasminogen Activators Inhibitors 
PCI Protein C Inhibitor 
Pcsk4 Pro protein convertase subtilisin/kexin type 4 
Pki p Protein Kinase Inhibitor beta 
Prm Protamine 
PRSS21 Protease, serine 21/ testisin 
PTU Propylthiouracil 
Ras GRP-1 Ras guanyl releasing protein 1 
Rhes Ras homolog enriched in striatum 
RNA Ribonucleic acid 
RT-PCR Reverse Transcription - Polymerase Chain Reaction 
Sert-1 Sertoli cell protein 1 
Sp10 Sperm Protein 10, Acrosomal vesicle protein 1 
Spam Sperm adhesion molecule 
Spink2 Serine protease inhibitor, Kazal type 2 (acrosin-trypsin inhibitor) 
Sycp Synaptonemal complex protein 
丁 4 Thyroxin 
TGF Transforming Growth Factor 
TIMP Tissue Inhibitor of Metalloprotease 
tMDC tissue-type, metalloproteinase-like, disintegrin-like, cysteine-rich protein 
TNF Tumor Nerosis Factor 
TPs Transition Proteins 
TRs Thyroid Hormone receptors 
UV260/280 Ultra Violet at the wavelengths of 260 and 280 nm 
Zfp37 Zinc finger protein 37 




Mammalian testes are responsible for the production of male gamete 
spermatozoa, and secretion of male sex hormone testosterone, which stimulate the 
development of masculine sexual characteristics. Whole testis is enclosed within a 
capsule tunica albuginea and muscle layers. The major constitutes of testes are the 
labyrinthine system of seminiferous tubules, and the surrounding interstitial tissues 
(interstitium). 
Interstitial tissue and Leydig cells 
The interstitial compartment contains blood and lymphatic vessels for 
nourishment of testicular cells. Apart from the connective tissue and lymphatic 
macrophages, the most important constitution of interstitial compartment is the 
Leydig cell. Leydig cells are responsible for the secretion of androgens that stimulate 
the differentiation of male tract during fetal life. During the development from fetus to 
adult, Leydig cells undergo transformation and proliferation until Day 60', when the 
number of Leydig cells remains constant and synthesis testosterone as their major 
secretion. 
Seminiferous tubules 
The convoluted seminiferous tubules make up more than 70% of adult rat testis. 
These tubules are covered by thick basal lamina and layers of peritubular myoid cells. 
The contractile myoid cells provide mechanical tension to expel the sperm together 
with fluid through the lumen�. The basement membrane is a specialized organization 
11 
I 
丨 I . . . 
‘I of connective tissue that assists in providing solid support for the tubule. The lumen 
I of seminiferous tubules is lined with the seminiferous epithelium which contains two 
‘ general types of cells: spermatogenic germ cells and Sertoli cells. 
I 
7 Male germ cell line and spermatogenesis 
i 
I 
I: Spermatogenesis is the process of male gamete production in which 
i 
, spermatogonia developed into spermatozoa. This progress can be divided into three 
! developmental phases with characteristic stages of germ cells: Mitotic phase 
I (spermatogonia), Meiotic phase (spermatocytes) and Post-meiotic phase 
I (spermatids)^. 
,3 1. Mitotic phase (Proliferative phase) 
I Mammals produce millions of sperms per day. In order to replenish the 
I germinal epithelium to sustain a constant number of available cells, a 
self-renewal mechanism is required. The first member of spermatogenesis is 
the stem spermatogonium, which is located nearest to the wall of 
seminiferous epithelium attaching onto basement membrane. In rats these 
cells appears as early as postpartum Day and can be further divided into 
two types: Type A spermatogonia are isolated and proliferative stem cells 
that are responsible for new generation of both Type A and B spermatogonia, 
while Type B spermatogonia are actively dividing and differentiating that 
are responsible for the formation of spermatocytes. At postpartum Day 
rat spermatogonium starts to differentiate and undergo a series of mitosis 
during which the nuclear compartment divided but remains cytoplasmic 
12 
I 
continuity known as intercellular bridges^ At the end of mitotic phase, 
matured portions of spermatogonia (type B) are developed to form young 
diploid primary spermatocytes. 
2. Meiotic phase 
After the post-mitotic differentiation, these primary spermatocytes enter the 
S-phase of cell cycle, arrested and become Preleptotene Spermatocytes. 
This meiotic phase is an extended and long-lasting period. Within this 
three-week period of time, the spermatocytes undergo gradual 
morphological transformations with sizes of cytoplasmic content increases 
progressively that can be easily identified under light microscopy. 
According to their nuclear histological organizations these spermatocytes 
can be further developed into leptotene, zygotene, pachytene and diplotene 
spermatocytes ,with their first time of appearance ranging from Day 9, 15, 
18 and 26 postpartum respectively^. Leptotene cells start the prophase of 
meiotic by condensation of chromosomes. During the transition of 
preleptotene to leptotene spermatocytes, these cells migrate from the Basal 
to the A luminal compartment of testis, where the intercalated Intermediate 
compartment^ is the site where tight junction of Sertoli cells located. 
Homologous chromosomes are paired in zygotene cells with the help of 
synaptonemal complex?, and the event of genetic recombination, crossing 
over, is initiated within pachytene cells. Together with the last diplotene 
cells, these mentioned diploid primary spermatocytes finish the prophase 
and rapidly complete the remaining metaphase，anaphase and telophase to 
ends the Meiotic I. After the first meiotic division, which is also known as 
13 
‘ ’ reductional division, two homologous chromosomes within each primary 
spermatocyte are separated and become two haploid secondary 
spermatocytes. Cells eventually enter the second meiotic division, Meiosis 
II or equational division, to produce four identical haploid Round 
Spermatids when the prolonged meiotic phase ends. 
3. Post-meiotic phase (Spermiogenic Phase) 
This terminal process of spermatogenesis is also celled spermiogeneis. 
During this process, the round spermatids undergo massive cytoplasmic 
transformation to develop into completely matured spermatozoa. Cell 
volume is significantly reduced with the development of flagellum and 
acrosome. Characteristic shape of sperm is formed by nuclear condensation 
and elimination of cytoplasm. Spermatozoa are ready to be released upon 
activation for fertilization of ovum. 
During the progress of spermatogenesis, the developing germ cells always 
remain attached and being surrounded by irregular-shaped Sertoli Cells. 
Sertoli Cells 
The Sertoli cells constitute up to 15% of testis content and contribute a very 
important role in assisting the establishment of spermatogenesis. The main function of 
Sertoli cells is to provide nutritive and mechanical support to hold the developing 
germ cells within its luminal crypts. It also secretes inhibin and activin, which 
regulates the positive and negative feedback on Follicle Stimulating Hormone (FSH) 
14 
I 
level. Another important function of these cells is the formation of blood-testis barrier 
(BTB). Within the testis, there are specialized types of cell junctions that are unique ^ 
around the whole body. Two adjacent Sertoli cells are linked together by tight junction. ； 
I I 
This barrier can restrict the entries of limited substance but still allow the diffusion of | 
I 
nutrients towards germ cells. Though having a great surface area, Sertoli cells have ‘ 
limited capacity on supporting the development of sperm, meaning that each cell can 
only sustain a particular number of germ cells to growth . In case of rats, the Sertoli 
j 
cell to germ cell ratio is around 1:50. This suggested that the potential adult sperm j 
production is heavily influenced by the number of Sertoli cells present on developed 
testis. While the importance of these cells is highly concerned, its proliferative period 
is relatively short. Sertoli cells are terminally differentiated cells that their amount 
will not be replenished upon lose. In rats, Sertoli cells cease dividing as soon as at i 
• j 
i 
postpartum Day 15^, thus increasing the mitotic activity during this period or I 
extension of proliferation period is a remedy for increasing the fertility of adults in I 
I 
I 
terms of sperm count. 
i 
I I 
Specialized organizations of junction present in testis 
As mentioned before, testis has unique junctional arrangements that are 
distinctive from other organs for communicating between cells and their surroundings. 
It is now demonstrated that three morphologically and functionally apparent types of 
cell junctions are present in the seminiferous e p i t h e l i u m T h e first one is occluding 
junction", which are generally called tight junction. Tight junction is formed between 
two adjacent Sertoli cells which divides the seminiferous epithelium into two 
permanents (basal and adluminal) and one transient (intermediate) compartment. The 
basal compartment contains spermatogonia and early stage of leptotene spermatocytes. 
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i 
Within this compartment, cells bear free access of substances from blood and the 
lymphatic circulation. Beyond the basal compartment is the adluminal compartment 
where the spermatocytes and spermatids reside. After meiosis, spermatids are haploid 
which are immunologically different with that of diploid cells. Thus tight junction is 
essential in blocking the circulating antibodies or foreign substances that may damage 
the developing germ cells. There is another putative intercalated partition named as 
intermediate compartment which will be discussed below. The second type of cell 
junctions is the anchoring (or adhering) junction, which can be further classified into j 
i 
I 
four main groups depending upon their nature and localization. These actios based or ； 
intermediate filament based junctions are present between Sertoli cells, germ cells and ； 
i 
the extracellular matrix. Their proposed function is to link the cells' internal 
I 
machinery or cytoskeleton to another cell or matrix in establishing a trafficking i 
network and maintain tissue integrity. The third type of cell junctions is the gap : 
junctions 12, which are intercellular channels that allow exchange of ions and small 
molecules between two cells. There are also testis specific junctions like ectoplasmic 
specialization 13 and tubulobular complexes 丨^  that hold the spermatids to avoid 
premature release. 
Dynamic nature of Sertoli-Sertoli & Sertoli-germ cell junctions 
Because of the high variety of junctions present in testis, a controlled mechanism 
is required to protect these machineries to function, especially during spermatogenesis. 
In order to escape from the immunogenic attack, cells need to migrate from basal 
compartment towards the adluminal compartment. It is supposed that within the 
transient intermediate compartment, leptotene spermatocytes or Sertoli cells need to 
secrete proteins that assist in successive formation and breakdown of tight junction to 
16 
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retain the integrity of blood-testis barrier. During the germ cell development, there is a 
unipolar migration of spermatocytes that needed to provide space for the continuous 
proliferation from basal spermatogonia. The mechanism of how the germ cells 
transversing across the densely packed epithelium is still an unanswered paradox. To 
achieve this migration, extracellular matrix and intercellular cytoskeleton were under 
a vigorous dynamics. Non-static disassembly and assembly of structural and adhesive 
molecules is required to remodel the microenvironment for conveying cells. During 
the migration, an adhesive force must be maintained to hold the differentiating 
spermatocytes attaching onto Sertoli cell lining for nourishment and protection, but at 
the same time a degree of stringent is also essential to allow pushing the matured 
spermatids away from basal compartment. These two counteracting forces must be 
fine-tuned in an organized manner: If the adhesion is too strong, developed 
spermatozoa cannot be released into lumen and will be phagocytized by Sertoli cells 
eventually. In contrast, undeveloped spermatocytes will be discharged prematurely 
that lost nutritive support and failed to fertilize an ovum. 
Role of proteases and protease inhibitors in male gametogenesis 
In order to adjust the microenvironment during spermatogenesis, either the 
secretory Sertoli cells or the developing germ cells need to release proteins that 
support matrix remodelling. Noticed that genes required for spermatogenesis and 
fertility often encode transcripts present in meiotic or post-meiotic germ cells but not 
in somatic tissue'^ Proteases are well-known for their involvements in cell movement 
of metastasis and invasion in cancer cells'^. Some members of protease are also 
important in the pathophysiology of extracellular matrix related disorder like arthritis, 
yet the role of protease in testicular development is still unclear. Proteases can be I 
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classified into four main classes according to their catalytic types: Cysteine, Aspartic, 
Serine and Metallo-peptidases. Both Sertoli cells and spermatogenic cells express 
intensive abundance of protease and protease inhibitors, but most of their specific 
substrates are still unknown. The high versatility of proteases may help remodelling 
by digestion of matrix proteins, or activating cytokines and receptors for signal 
transduction. To avoid non-specific degradation, proteolysis must be controlled at 
specific site, thus specific protease inhibitors are required. It is important to evidence 
here that during tissue remodelling, proteases are only activated at specific site of 
action, while the activity at other sites is always suppressed with presence of 
inhibitors. Some members of proteases [like tissue Plasminogen Activators (tPA) and 
Cathepsins] and protease inhibitors are well characterized for their contributions in 
spermatogenesis, but another family of growing awareness are the A Disintegrin and 
Metalloproteases (ADAMs). 
Proteases and Proteases Inhibitors expressed in testis 
ADAM is a growing member of metalloprotease which belongs to the zinc 
protease family, metzincin subgroup. There are seven dedicated domains for different 
putative functions: (1) Pro-domain, which activates the ADAMs upon cleavage. (2) 
Metalloprotease domain, which perform shedding and cleavage of proteins. (3) 
Disintegrin domain, which bind with integrin subunits. (4) Cysteine-rich domain, 
which supports syndecan-mediated adhesion. (5) EGF-like domain, which stimulates 
membrane fusion in some ADAM candidate. (6) Trans-membrane domain, where the 
ADAM protein anchors on (7) Cytoplasmic tail, which binds with different signalling 
molecules and receptors口. Up-to-date, there are at least 39 ADAMs genes identified 
in different species, among which at least 15 of them are testis specific or 
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饼edominantly expressed. The intensified abundance expressed in a sole organ proven 
that the role of ADAMs in testicular development should not be underestimated. 
Another closely related family is the A Disintegrin And Metalloprotease with 
Thrombospondin-like motifs (ADAMTS). ADAMTS still possess Pro-domain, 
metalloprotease and disintegrin domain but lack the remaining domains, replace by 
repeats of thrombospondin-like sequence. These repeats may mimic the function of 
adhesive domains that ADAM bears, since thrombospondin is know to interact with 
cell surface molecule- sulfated glycosaminoglycan. The functions of some members 
of ADAMTS have been described for long. For example ADAMTS-2, which is 
previously called Procollagen N-proteinase, is responsible for proteolysis of type I 
and II collagens — the main component of extracellular matrix. Under the metzincin 
subgroup (where ADAM and ADAMTS belongs to), there are also matrix 
metalloproteases (MMPs)丨 8 which are enzymes that responsible for degradation of 
matrix and wound healing. Testis also expresses high level of protease inhibitors, for 
example the Tissue Inhibitors of Metalloproteases (TIMPs), which known to suppress 
the activity against a wide range of metalloprotease, and cystatins, specific inhibitors 
of cysteine proteases like the cathepsins. Common protease inhibitor like 
a2-macroglobulin (a2MG), together with other specific inhibitors may help 
protecting against the attack of proteolysis done by ADAMs. 
Hormonal control of spermatogenesis 
Hormonal control over the male gamete development has been studied 
extensively over the past half century, especially the example of FSH. From different 
experimental designs (hemicastration, GnRH antagonist or recombinant FSH 
treatment) 19, it is well known that FSH can directly enhance fertility through its 
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mitogenic activity^^. During the fetal development of rat, FSH stimulates the division 
of both Sertoli cell and spermatogonia during the proliferative phase, thus increasing 
the testicular mass and number of Sertoli cells at the adult stages. Sertoli cell will also 
produce inhibin and activins that feedback to the pituitary to inhibit the secretion of 
FSH. Another known pituitary hormone that helps sperm production is the Luteinizing 
Hormone (LH). LH stimulates the production of testosterone from Leydig cells, 
which is an essential component in generating a microenvironment of Sertoli cells for 
gamete differentiation. Yet the physiological control of FSH, LH and testosterone is 
well characterized^', the role of thyroid hormones on testis development is not clearly 
understood because of the paradoxical distributions of thyroid hormone receptors 
(TRs) among each testicular cell types. Classical studies suggested that adult testis is 
unresponsive to thyroid hormone due to the undetectable expression of any TRs on 
the entire adult testis^". Recent RT-PCR and immunochemistry studies revealed that 
members of TRs expressed in particular period during the developmentZ], while 
Sertoli cell is regarded as the main target of thyroid hormone in testis. Thyroid 
hormone receptor (TRal in particular) for example only expressed in early stages of 
developing spermatocytes (from intermediate spermatogonia to pachytene 
spermatocytes). More interesting findings uncovered that expression of TRal on 
Sertoli cells is only limited at the time when they are dividing, and their expressions 
started to be eliminated after the cessation of proliferation period of Sertoli cells. This 
clearly states that thyroid hormones play an important role on the proliferation of 
Sertoli and germ cells within a critical period. 
20 
hypothyroidism and testis development 
The use of neonatal hypothyroidism as a model of studying testis growth is well 
established and its effect is considerably great. Induction of neonatal hypothyroidism 
by 0.1% propylthiouracil (PTU) can increase the number of Sertoli cells and testis 
mass in adult by 182-257% and 127-162% respectively""^. Other parameters reflecting 
the fertility also increased significantly (for example the interstitial volume increased 
by 60%, while Daily Sperm production has elevated by 140%^^). In contrast, 
hyperthyroidism causes a lost of 50% of Sertoli cells with half-weighted testis^^. 
Propylthiouracil is a reversible goitrogen. Upon ingestion by mother rats, it passes 
through milk and causes severe hypothyroidism in pups.^^ However the use of PTU 
as low as 0.006% could increase testis size and sperm production maximally with 
minimized side effects.^^ Hormone profiles from radioimmunoassay studies shows 
that under 0.1% PTU treatment, testosterone level is normal-^, while FSH and LH 
were 40%-50% lowered despite the increases in testis size and sperm count. 
Together with the TRs expression profiles, these data indicate that thyroid hormone 
may play an indirect role in inducing the increase in Sertoli cell number, but not in a 
mitogenic manner. Thus it was proposed that hypothyroidism may slow down the 
maturation of Sertoli cells, which extends the available time for mitosis]�This means 
that thyroid hormones may indirectly stimulate the differentiation of Sertoli cell in 
neonatal period, with their actions independent from FSH, LH or testosterone. It was 
even proposed that the disappearance of mild perinatal hypothyroidism (due to the 
adequate intake of iodine) may be involved in the reduced fertility in urbanized 
citizens when compared with that of the starved. 
21 
Henes to be studied: 
In order to identify genes that may be affected by hypothyroidism during rats' 
postnatal development, a temporal expression profiling of different genes were carried 
out. Proteases and their endogenous inhibitor are especially emphasized. 
Proteases: 
ADAM 2’ which is previously named as fertilin (3 or PH-30, is well known for its 
role in sperm-egg fusion during fertilization. Upon dimerization with ADAM 1，the 
fertilin complex on sperm is able to interact with a6(31 integrin on egg surface for 
membrane fusion 32. Knockout studies have shown that rats lacking ADAM 2 
expression are infertile but healthy, while the sperm suffered an eight fold decrease in 
binding capacity to egg^l 
ADAM3, which is also named as cyritestin or tMDC I (tissue-type, 
metalloproteinase-like, disintegrin-like, cysteine-rich protein I), is first characterized 
as a trans-membrane protein involved in fertilization. Cyritestin was another 
testis-specific ADAMs that proposed to be a sperm protein involved in gamete 
interaction and sperm-egg plasma membrane adhesion and fusion�^. 
ADAM4 (tMDC V) is predominantly expressed in testis, but low abundance of 
transcription is also found in other tissues like heart^^ Inhibitory loop peptide analogy 
with ADAM 4 has no effect in affecting the sperm-egg fusion^^, which means this 




‘ ADAM5 (tMDC II) is first characterized as a testis-specific gene that was 
identified together with ADAM 4 and 6 from a screening of mouse cDNA library in 
testis. With increased sensitivity, low transcription was also detected in brain, kidney, 
and ovary. ADAM 6 (tMDC IV) is predominantly expressed in testis, and detectable 
expression is also present in prostate. 
ADAM15, also called Metargidin or MDC 15，was isolated from a human 
mammary epithelial carcinoma cell line and is widely expressed]?. About half of the 
presently known metalloprotease disintegrins carry a catalytic site consensus 
sequence for metalloproteases (HEXXH) and are therefore predicted to be 
catalytically active, whereas the remaining family members do not contain a catalytic 
site in an otherwise related metalloprotease-like domain and therefore must lack 
metalloprotease activity. ADAM 15 is one of the members of ADAMs that bear active 
metalloprotease activity�^’ and is known for its ability interacts with av(33 integrin. 
ADAM18 (tMDC III) is a protein processed on the sperm surface during 
epididymal transit-'^. From human orthologues studies revealed that ADAM 18 
contains putative integrin-binding Glu-Cys-Asp (ECD) motif^® that may facilitate 
oocyte recognition during fertilization similar to ADAM 2 and 3. 
ADAM30 was identified by Northern Blot against human testis cDNA library, 
where its expression is testis specific"^'. The identification of this novel gene is new 
and thus its role in fertilization or spermatogenesis is not yet characterized. 
ADAM32 is one of the most-recently identified members of ADAMs family. It is 
known that ADAM 32 gene is predominantly expressed in the testis. Northern Blot 
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afld RT-PCR data revealed that expression of ADAM 32 begins during the meiotic 
stage, where pachytene spermatocytes are their major expression location"^ .^ 
ADAMTS-1 (METHl) is well known for its inhibitory effect on angiogenesis 
due to its thrombospondin-1 repeats. It is an active protease associated with ECM and 
essential for normal growth, fertility, and organ morphology. Unlike the 
transmembrane ADAMs family that cleaves membrane surface proteins, ADAMTSs 
are soluble, secretory extracellular matrix proteins, thus substrates that can be 
processed by ADAMTSs are rather well-illustrated. There are matrix metalloprotease 
(MMP) cleavage sites in its spacer domain'^^, thus the interaction with other proteases 
upon activation is proposed. With its high homology with AD AMIS 4，AD AMIS 1 is 
able to cleave cartilage proteoglycan, aggrecan and versican at similar sites. 
ADAMTS-4 is also called aggrecanase-1. ADAMTS-4, together with 
ADAMTS-5/11, is regarded as aggrecanase that involved in degradation of aggrecan, 
a cartilage protein involved in the pathophysiology of arthritic diseases. Its activity of 
proteolysis can be regulated by other proteinases or inhibitors. For example, it can be 
activated by another family of proteases, the MT4-MMp44. But can also cleave the 
global protease inhibitor or inhibited by TIMPs, especially TIMP-3. 
ADAMTS-5 (aggrecanase-2) cleaves aggrecan at different sites �6 • This 
ADAMTS-5, together with TS-1 and TS-4, has been shown to degrade members of 
the lectican family of proteolycan"^^ suggesting that they have important roles in the 
remodelling of ECM. Notice that thyroid hormones can up-regulate the expression of 
ADAMTS-548, suggests that thyroid hormones may assist in degradation of ECM 
components indirectly under the regulation of secretory proteases. 
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ADAMTS-16 was first cloned in human cDNA library, where lung, kidney, brain 
and ovary are the main encoding location"^ .^ Here we report the temporal transcription 
of putative ADAMTS-16, with the primer sequence based on the mice homolog. 
The matrix metalloproteinases (MMPs) are zinc metalloproteases that can 
possibly degrade all structural components of the extracellular matrix like type III 
collagen, proteoglycan, gelatine and fibronectin. This family of endopeptidase is also 
able to active a number of cytokines and other proteases, thereby their role in 
developmental physiology in tissue remodelling is well known. MMPs can be divided 
into secreted from or membrane-type form. The proteolytic activity in latter form 
(MT-MMP) can be regulated by TIMPs and is highly specific. Membrane type 3 -
Matrix Metalloprotease (MT3-MMP), which is also called MMP-16, is shown to 
activate another potential protease, pro-MMP2. This cleavage is subjected to 
inhibition to TIMP-2 and -3, but not -1)0. It was shown that upon autocatalytic 
processing and ectodomain shedding, MT3-MMP is potent to digest type III collagen 
than other MT-MMP members. 
The metalloprotease Angiotensin I Converting Enzyme (ACE) is an 
ectoenzyme anchored on plasma membrane that plays a pivotal role in the 
cardiovascular system by generating the vasoconstrictor peptide angiotensin 11 '^. In 
the mammalian testis, two isoforms, namely somatic and germinal ACE are known. 
Although both forms are present in testis, the testicular isoform (tACE) is exclusively 
expressed during spermatogenesis. A soluble form of ACE can be derived from 
membrane-anchored form, which can be found in many biological fluid like seminal 
fluid and amniotic fluid. It was shown that mice lacking ACE expression suffered a 
reduced fertility by failure in oocyte recognition. But its best-known substrate, 
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smgiotensinogen, is not fertility-related^^, indicating that other substrates maybe 
involved in the role of spermatogenesis by ACE. 
Neprilysin (Nep) is a transmembrane ectopeptidase under the zinc 
metalloprotease family, where its main expression is localized on the brush-border 
membrane of kidney. Nep bears conserved cysteine residues in extracellular domains, 
which may be essential for the maintenance of its structure and function upon 
activation by other proteases^^. Its substrate includes vasodiliators such as atrial 
natriuretic peptide, and some neuropeptides like substance P. No natural inhibitors of 
Nep have been identified, in which TIMPs cannot exert its inhibitory effect on it. Its 
biological importance in reproduction is not yet characterized, but Nep is 
down-regulated in prostate cancer to facilitate the tumour progression, possibly by the 
stimulation of mitogenic peptides)^. 
PRSS21/Testisin is a recently characterized homolog of human serine protease. 
PRSS21 was abundantly expressed in testis and lost in testicular tumors, thus it was 
considered as a putataive tumour suppressor gene. Immunostaining revealed the 
expression is limited to the cytoplasm and plasma membrane of premeiotic germ 
cells55. The physiological peptide substrates have not been identified, but mice 
PRSS21 shows gelatine-hydrolysing ability that proposed to assist fertilization^^. 
Plasminogen Activators (PAs) are specific serine proteases that catalyze the 
conversion of plasminogen into plasmin, a protease with trypsin-like substrate 
specificity. Some specific factors of the PA system are known: the activators, tissue 
type activator (tPA) and urokinase type activator (uPA) whose activities are 
controlled by two serine plasminogen activator inhibitors, PAI-1 and PAI-2. Sertoli 
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cell cultures secrete plasminogen-dependent proteases into medium that can be 
regulated by FSH level, thus PAs are extensively studied for their roles in fertility by 
Sertoli cells. Major constitutions of PAs are synthesized by Sertoli cells, but still a 
lower amount of expression can be detected in spermatocyte extracts. 
Proteases Inhibitors: 
Activities of the ADAMs, ADAMTSs and MMPs can be inhibited principally by 
the four Tissue Inhibitors of MetalloProteinase (TIMPs). For example, TIMPs 
inhibits most of the MMPs in a 1:1 stoichiometric ratio口. Each member of TIMPs has 
high specificity and independent inhibitory activity over different metalloproteases. 
In case of TIMP-1 as an example, it potentially suppresses activity of all MMPs, but 
a reduced capacity on inhibiting some matrix-bounded family members is shown 
(MMP-14, -15, -16’ - 2 4 ) O n e of the most well-known inhibitory targets is 
Gelatinase B (MMP-9), which suggested that TIMP-1 play important role in processes 
that involves tissue remodellling like tumour invasion and organ morphogenesis. 
Apart from the inhibitory effect against peptidase, it was proposed that TIMP-2 
can also act as a receptor. The binding of TIMP-2 to MTl-MMP can form a complex 
that acts as a receptor for pro-Gelatinase A (MMP-2) for activation to digest a great 
variety of collagens. Expression of these molecules is modulated by FSH and is 
therefore its role in spermatogenesis is implicated^ 
Unlike TIMP-1 and TIMP-2 which is in a soluble form, TIMP-3 is an 
ECM-associated protein with distinct expression with that of the previous ones^^. 
Similar with other members, TIMP-3 is also able to inhibit all known MMP family 
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members^'. Studies pointed out that TIMP-3 maybe involved in the morphogenesis of 
certain epithelial structures, and in placental implantation^^. 
TIMP-4 was first cloned in human cDNA library and is abundantly expressed in 
heart^^. Its transcription in other parts is restricted, where very low level was detected 
in the kidney, placenta, colon, and testes, suggested that TIMP-4 may play 
tissue-specific inhibition with is distinct with other TIMPs. Unlike TIMP-3 which has 
a unique association with the ECM, TIMP-4 binds to the COOH-terminal 
hemopexin-like domain of MM?-9^\ and both TIMP-4 and MMP-9 were expressed 
in both Sertoli cells and gonocytes^\ 
AIpha-2 macroglobulin (a2MG) is a secretory product of Sertoli but not germ 
cells. Its uniqueness is reflected by its ability to inhibit the proteolytic activity of all 
classes of proteases and is widely expressed. In testis, it was localized to Sertoli cell 
cytoplasm and around the heads of elongating and elongate spermatids possibly at the 
site of apical ectoplasmic specialization, suggestive of its significance in germ cell 
movement and spermiation. Neither FSH nor androgens affect the secretion, thus it 
was postulated that a2MG might limit unwanted proteolysis to maintain the integrity 
of Sertoli cell barrier, since extensive cytoplasmic remodellling in the seminiferous 
epithelium is continuous during spermatogenesis^^. 
Bikunin, also called urinary trypsin inhibitor (ulinastatin) is a Kunitz-type serine 
protease inhibitor that is first characterized in cancer cells. Together with a l 
microglobulin, bikunin is produced by post-translational processing of their common 
ai-microglobulin/bikunin precursor ^^. Bikunin has two Kunitz-type proteinase 
inhibitor domains, and is proposed as a main participant in suppression of tumor cell 
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invasion and metastasis possibly through inhibition of urokinase-type plasminogen 
activator (uPA) and limit collagen synthesis. 
Cystatins are specific, potent and reversible inhibitors of the CI family of 
papain-like cysteine proteases, including the mammalian cathepsins B, H, L, and S^ .^ 
Cystatin 8, which is also named as cystatin-related epididymal spermatogenic protein, 
is predominantly expressed in proximal caput region of the epididymis, 20-fold more 
than in testis^^. 
Cystatin C (Cystatin 3) is thought to be a member in the pathogenesis of 
Alzheimer disease by its amyloidogenic ability that colocalizes with beta-amyloid. 
Cystatin C displays the strongest inhibitory activity of all cystatins toward lysosomal 
cysteine proteases in general and has a widespread distribution in human tissues and 
body fluids, including cerebrospinal fluid, seminal plasma, and milk?�. 
Cystatin-related gene expressed in Sertoli cells (Cystatin SC) and 
cystatin-related gene highly expressed in testis and epididymis (Cystatin TE-1) are 
recently identified members of cystatins superfamily by the use of differential display 
RT-PCR^'. Cystatin SC was only detected in testis and Sertoli cell cultures by 
Northern blot analysis, while no apparent expression was found in spermatogenic 
cells or epididymis by in situ hybridization. 
Unlike Cystatin SC, Cystsatin TE-1 has a wider expression location. Northern 
Blot revealed that gene was also present in proximal epithelium of epididymis, and 
Sertoli cells. Weak signals were also detected in ovary and prostate but not in other 
tissues. But the expression of Cystatin TE-1 is absent in spermatogenic germ cells and 
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fc^ydig cells. 
Protein C inhibitor (PCI) is a nonspecific, heparin-binding serpin (serine 
protease inhibitor) that inactivates many plasmatic and extravascular serine proteases 
by forming stable 1:1 complexes. As it's another name imply, Plasminogen inhibitor 
type-3 (PAI-3) are predicted to be involved in the restructuring events that 
characterize the testis throughout development. Proteases inhibited by PCI include the 
anticoagulant activated protein C, the uPA, and the sperm protease acrosin^". The 
main source of PCI is Leydig cells. Null mice lacking PCI expression are healthy but 
sterile in male with malformed sperm. 
Other spermatogenesis related genes: 
Calmegin (Clgn) is expressed in meiotic-germ cell, localized on ER membrane 
and is testis specific. In spermatogenesis, the Clgn protein is thought to act as a 
chaperone for proteins in transition from endoplasmic reticulum to the spermatid 
surface^^ The chaperone function of clgn, with expression initiated in late pachytene 
spermatocytes, is though to assist in the post-translational folding of feitilin complex 
that assist speiin-egg interaction during fertilization. 
Heparan sulfate proteoglycans are important candidate in regulation of cell-cell 
adhesion and signalling. Syndecans is one of them that most extensively studied in 
testis for their ability to bind with varies ECM molecules and messagers. Of which, 
syndecan-4 is localized on focal adhesions and their association with actin 
cytoskeleton suggested that it may participate in remodelling of testicular 
environment^'^. It was suggested to be a co-receptor together with the integrins to 
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Bring upon the cytoplasmic signalling and adhesive functions through PKC 
pathway?). 
Tight junction is a multi-molecular membrane specialization. Occludin, claudins 
and several associated peripheral proteins such as ZO-1, -2 and -3 are main 
integration components that forming the trans-membrane domains in Sertoli cell 
barrier^^. Tight junction dynamics are supposed to be regulated by several signalling 
pathway like TGF(3 and protein kinases A and C??. 
The cadherin superfamily represents a group of calcium-dependent cell-surface 
glycoproteins meditating cell-cell recognition and morphogenesis^^ Cadherins are 
well known for its participation in adhering junctions which found between Sertoli 
cells or Sertoli-Germ cells^^. The machinery of cadherins is dependent on two factors: 
calcium and binding with catenin. It was shown that in the lack of calcium, cadherins 
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are inactive and susceptible to proteolysis . Upon binding with (3- or y-catenins, the 
cadherin-catenin complex is able to anchor onto the cytoskeleton by a-catenin to 
facilitate the construction of adhering junctional. Here we characterize the putative 
homolog of mice Cadherin-8 (Cdh8) in rat testis, in which the encoding of it is 
strictly limited in developing CNS for mouse . 
Synaptonemal complex protein 1 (Sycpl) encodes the major component of 
synaptonemal complexes. Synaptonemal complexes are structures that are formed 
between homologous chromosomes during meiotic prophase, which is a key 
candidate involving the chromosome pairing and genetic recombination. 
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Physiological effects of thyroid hormones are mediated by thyroid hormone 
receptors (TRs) which also serve as nuclear ligand-modulated transcription factors 
upon activation. TRs are encoded by two genes, alpha and beta, which are subjected 
to alternative splice to form different isoforms. In testis, TRal is exclusively 
expressed in Sertoli cells and trace transcription is also found in germ cells, but its 
expression is largely limited in cells during developing state. Expression of TR beta 
isoforms is not consistent among different studies and is rather paradoxical. Together 
with other binding assay, Thyroid Hormone Receptor a l (TRal) is though to be the 
Q -> 
main target of thyroid hormone in testicular environment 
Objectives: 
Through the study on temporal expression on a variety of protease and protease 
inhibitors, we would like to use the neonatal hypothyroidism as a model of study to 
investigate the developmental profile of these genes. This may help us to understand 




• Materials and Methods: 
Animal treatments and tissue collection: 
Pregnant Sprague-Dawley rats were housed individually under controlled 
temperature (20士 1°C) and photoperiod (12L/12D) with free access to rat chow and 
water. The animal care and experimentation procedures were done in accordance with 
Guide lines approved by the local animal experimentation ethic committee. Some 
litters were made hypothyroid by adding either 0.1% propylthiouracil [PTU; Sigma, 
St. Louis, MO] (w/v) in the mother's drinking water from day 4 to day 24. At day 24, 
at which time control pups were weaned, no further treatments were given. Rats from 
both control and PTU-treated litters used for studying the transcription of ADAMs 
and ADAMTSs genes were killed by rapid decapitation at days 24, 30, 40，50, 60 and 
90. Body and testis weights were measured. Testes were snap-frozen in liquid 
nitrogen and stored at -70°C until extraction of total RNA using the Qiagen RNeasy 
mini-kit (Hilden, Germany). 
In order to investigate the expression of non-spermatogenic genes at neonatal 
period, control and PTU-treated rats that caged in same conditions were scarified at 
the age of day 8’ 16 and 24 and subjected to other RT-PCR procedures as described 
before. 
To validate our experiment if alternation of gene expression is thyroid hormone 
responsive, another set of experiment was carried out with a thyroxin (T4) 
replacement group. Together with the control and hypothyroid groups as previously 
described, same litter size of PTU-treated rats were injected with one dose of 240 ng 
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了4 per kilogram body weight subcutaneously at day 35. All three groups of rats were 
killed at day 40 or day 50 and subjected to further procedures as mentioned. 
Using the same laboratory setup, other six groups of pups were caged and cared 
under same conditions. Different induction of hypothyroidism was applied by 
changing the concentration, exposure duration and goitrogen that applied to mother 
rats' drinking water. In the first two groups, mothers were fed with tap water and 0.1% 
PTU from postnatal day 4 to 24 respectively as previously mentioned for comparison. 
In the third group, same concentration of PTU was applied with shortened duration 
from postnatal day 4 to 16 only to study its period of action. In the remaining groups, 
another goitrogen, methiamzole (MMI) was used. In the 4出 group, 0.05% MMI was 
administered from Day 4 to 24 postnatally in mothers' drinking water to compare its 
potency with that of PTU. In the 5出 group, a prolonged hypothyroid induction was 
initiated by applying 0.05% MMI as soon as prenatal day 17 to postnatal day 26 to 
investigate the effect of exposure duration. Finally in the last group, a much lowered 
concentration at 0.0125% MMI was used to see whether the mild hypothyroidism can 
affect the expression of target genes examined in this study. 
RNA preparation 
Total RNAs were prepared by the Qiagen RNeasy mini-kits. Total RNAs were 
quantified by UV260/280 measurement in a Gene Spec I spectrophotometer (Hitachi 
Genetic systems, CA.). Reverse transcriptions were performed using 50 |j.M poly 
dTi2-i8 as primer, 6 |ig total RNA, 200 U SuperScript II RNase H" reverse 
transcriptase, 10 mM dNTP (Invitrogen Life Technologies, CA.) in DTT enriched IX 
first strand buffer at 70°C for 10 min, 37°C for 1 h and an inactivation process at 
90°C for 5 min using an DNA Engine (MJ Research Inc., USA). After all, the 
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RT-products were cooled to 4°C, aliquoted to smaller portions and stored at -30°C 
until the real-time PGR processes. 
RT-PCRs: 
The RT-products were diluted to a concentration of 20 ng/}il for the subsequent 
PCRs. Equal amount of cDNA of all samples were pooled to form a large sample pool 
for the construction of standard curves for individual target gene in the following 
study. The conditions of the PGR such as Mg++ concentrations, annealing temperature 
were optimized before the RT-PCRs and real-time PCRs. The size of individual target 
gene was confirmed by running the PGR products in 2% agarose gel with 0.5 mg/ml 
ethidium bromide in IX TAE buffer (40 mM Tris, 20 mM sodium acetate, ImM 
EDTA, pH 7.2) with 50 b.p. or 100 b.p. DNA markers running parallel to the target 
gene samples. 
Real Time PCRs: 
For real-time PCRs, either the SYBR Green® core kit and the ABI PRISM™ 
7700 sequence detection system (Applied Biosystem, CA) or a Platinum Tag DNA 
polymerase (Invitrogen Life Technologies, CA.) based home-made PCRs and the 
Bio-Rad iCycler iQ® Real-time PGR system (Bio-Rad, CA) were used. Standard 
curves of target genes were made using the pooled RT products from all samples at 
the final concentrations of 0, 1.25, 2.5, 10, 40, 100 and 200ng. For each sample, a 
final concentration of 40ng of cDNA was subjected to PGR amplification in 
duplicates. A final reaction volume of 50 |j.1 was used in all the Real Time PCRs with 
amplification environment optimized as in RT-PCRs. Melt-curves of each target gene 
in individual reaction wells were used to verify the production of single band in the 
individual well. 
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The amplification curve (top-left), melt curve (top-right) and the standard curve 
calibration (bottom) of the ADAM6 genes that were generated by the Bio-Rad iCycler 
iQ® Real-time PGR system. High correlation coefficient and PGR efficiency with 
single-peaked melt curve was ensured in each of the genes being studied. 
Data manipulations and Statistics: 
Results of the PCRs for individual target genes were normalized with (3-actin as 
housekeeping gene. Expression of P-actin is tested in all samples not to be affected by 
age, treatment and their interactions in the experiment. The transcription of 
housekeeping (3-actin in each individual samples (in ng) were divided by the median 
value of all the samples (also in ng) to obtain a normalization factor. The relative gene 
expression value of each individual sample is obtained by correcting the raw 
expression data (as calculated from the standard curve calibration; also in ng) with the 
normalization factor. All data were subjected to statistical calculation by 2-way 
analysis of variance (ANOVA) using the statistical package SigmaStat 2.03 for 
Window (SPSS Inc., IL). In case the collapse of one factor in the analysis, either 
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one-way ANOVA followed by Tukey's test for multiple comparisons or the 
non-parametric Kruskal-Wallis one way ANOVA on ranks followed by Dunn's test for 
multiple comparisons was used for comparing data pairs (Illustrated as number-pairs 
in the figure). For the comparisons of two samples either the unpaired Student's t-test 
(two-tailed) or the non-parametric Mann-Whitney Rank Sum test was used (Illustrated 
as alphabet-pairs in the figure). 
Table 1: Primer sequences used in this experiment: 
Sense sequence Sense sequence 
Gene — - Gene . . . . . : 








Activin pA Act 
GCATTACCTTTCGGGTCCCT TTTCTGGGTCAAGAATCCTTCC 
GGCCCAGCAGAGAGATGTTC CATGCTGTAATCCCACCACC 











TGCCAGGCCAI I I I IGGACG GGTAACGAGACGGAATGTCAA 















知一 Sense sequence Sense sequence 
Gene Gene 





Calpain I Cadher in- l l 
GCATAGGCTTTCTCCAGGAGAGC GGTCCCCAGTTCTGTAGATAGT 
GAAGCCGGTGATGTGATGGGAGGC AGTCTTGGACAAAGACAGC 
Cathepsin 已 Calpastatin 
CAACCTTGCTGAAGCTTCATGC AGTCTTCTTACCCTTCTCC 
GAACGCCTTCGGTGACA TTAGCCCTGTTCGAAACCAAGAAT 












Cx43 CREM8 — 
ACGAATATGATCTGAAGGAC TTTTCAAGCACAGCCACACG 
AACGATGCGTACCACAGC GTGAGGACAAATACCTCTTCC 
Cystatin C Cystatin 8 
TGCAGCTGGATTTTGTCAGG TGCTCCTACCAGAAAGCTGC 
TTAGTAGACCTGGAGATGGG TTGCTAGAAGTTGGGAGAGC 
Cystatin TE-1 Cystatin SC 
ACAGGTGCTGTTCAAGATGG AAGTGGGAAAACCAAGGTCG 
TGAAGACTCCCGATTCAAAGT TCGTCATGGAAGCAAAGC 
E-Cadherin ~ ~ • — — — Dnc id 
TTGATTTTCCGGGCAGTTGAT AGTCACCTACTGCAACTTCC 
CAGCAGCAGTGAAGAGATGC AAGATACTGGCCTCTGTACC 


















一. Sense sequence Sense sequence 
Gene Gene 






















































Body and testis weights, together with the transcription profiles of each gene are 
shown in the following paragraphs. Unless specified, solid black bars represent the 
data in control rats, while solid grey columns denote that of the PTU-treated rats 
suffered from neonatal hypothyroidism. X-axis showing the age of rats being scarified 
is not in a linear scale. Vertical bars with ticks represent the arithmetic mean 士 
standard error of mean within each group. Numbers on top of the columns show 
statistical significance between the data pair by multiple comparisons. Paired 
alphabets show statistical significance by unpaired Students' t-test or Mann-Whitney 
Rank Sum test. For simplicity, * represents p<0.05, ** stands for p<0.01 and *** 
denotes for p<0.001 for significantly greater values during pair-wise comparisons. 
Screening data is also attached for relevant discussions. 
Effect of neonatal hypothyroidism on the developmental profile of body weight, 
absolute and relative testis weight: 
Body Weight 
As shown in Fig 1.1, hypothyroid rats are all significantly lighter than controls. 
Drastic reduction of 50% off the total body weight was found from day 30 to day 50. 
Hypothyroid rats still suffered an 18% decreased in size, and are not able to recover 
back to normal until day 90. All data pairs comparing the body weight of normal and 
hypothyroid rats are significantly differed. 
Absolute Testicular weight 
As illustrated in Fig 1.2, the absolute testicular weight is always significantly 
smaller in hypothyroid rats until day 60, where a smaller decrease was noticed. 
Ultimately the testis sizes in hypothyroid rats were 40% larger than normal at day 90. 
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Relative Testicular weight 
In Fig 1.3, the relative testicular weight, which is the division of absolute 
testicular weight over total body weight, revealed a developmental change. Though a 
40% decrease was profound between day 24 to 40 (* and ** stand for p<0.05 and 
<0.01 respectively), drastic rebound can be illustrated after the age of sexual 
maturation after day 50 (** and *** represents p<0.01 and <0.001 respectively). 
Body Weight 
500 -| h H Control 
I 1 PTU ** 
400 - *** • 
f 300 - • � 
.g) *** • 
I 200- T I , I 
j j j j l l l l 
24 30 40 50 60 90 
Age (Day) 
Fig 1.1 Changes of total body weight during development. ** and *** denote 
p-value smaller than 0.01 and 0.001 respectively using unpaired Student's t-test 
(Two-tailed). 
41 
Absolute Testicular Weight 
6000 -] 
• • 1 Control 




1 - j i 
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3 3000 - * f^ *** m^ 0) 2000 - _ • 
1 � � � - … • In • 
I ^ l i I X 
24 30 40 50 60 90 
Age (Day) 
Fig 1.2 Changes in testis weights during development (per paired testes). 
Unpaired Student's t-test revealed significant differences as denoted by ** and ***, 
which represents p-value smaller than 0.05, 0.01 and 0.001 respectively. 
Relative Testicular Weight 
16 -] 
• • i Control 
14 - • PTU ** 
* * ^ 
：£ 12- i ... 
i h ^ 10- n ^ 
lyjMi— 
24 30 40 50 60 90 
Age (Day) 
Fig 1.3 Changes in relative testicular weight during development (per paired 
testes). * represents p<0.05, ** stands for p<0.01 and *** denotes for p<0.001 for 
significantly greater values during pair-wise comparisons. 42 
Developmental transcription profiles of genes under normal and hypothyroidism 
ADAM2: 
As illustrated in Fig 2.1, transcription of ADAM2 gene is found to be 
significantly affected by the effects of age, treatment and their interaction (results of 
2-way ANOVA after logio transformation; p<0.001). Multiple comparisons indicate 
significant higher transcription of the control rats at day 40 than at day 24. 
Significantly higher transcription levels in the neonatal hypothyroid rat testis are 
observed between testes at day 60 and 24 as well as day 30. At day 40, significant 
higher transcription levels are found in the control rats. 
ADAM2 
• • I Control 
‘ 100 -1 I ~ n PTU 
I l,a 
① 
I 80 - I I T T 
i 6�- T • B 1 3 1 
I I i ? | i I ' 
• • • • 5 • 
I L | l | I 
o J _ 3 _ 丨：丨 _、 ,丨 _ I _ I _ _ 
24 30 40 50 60 90 
； A g e (Day) 
Fig 2.1 Transcription Profile of ADAM2 gene. Numbers on top of the columns 
！ show statistical significance between the data pairs by Dunn's test with p<0.05. "a" 








As shown in Fig 2.2, transcription of ADAM 3 gene is significantly affected by 
age (p<0.001) and treatment (pO.Ol) but not by their interaction [results of 2-way 
ANOVA after square root transformation]. Multiple comparisons indicated that 
between the control rats at day 24 and 90 and the neonatal hypothyroid rats at day 24 
and 60; 30 and 60 as well as day 24 and 90; 30 and 90’ significant higher transcription 
levels are observed in the older rats. Using pair-wise comparison to evaluate the 
control and neonatal hypothyroid rats at day 24 and 30, significantly higher 
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show statistical significance between all the data pairs by Dunn's test with p<0.05. 
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As indicated in Fig 2.3’ transcription of ADAM4 gene is significantly affected by 
age, treatment and their interaction (results of 2-way ANOVA after logio 
transformation: p<0.001). Transcription of this gene in the control rats reaches the 
adult's levels at day 40, while the catch-up of the neonatal hypothyroid rats starts at 
day 60. At day 40 and 50，control rats have higher transcription levels than the 
neonatal hypothyroid rats. 
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Fig 2.3 Developmental transcription profile of ADAM4 gene. Numbers on top of 
the columns show statistical significance between the data pairs by Dunn's test with 
p<0.05. Paired alphabets show statistical significance by pair comparison, a: unpaired 
t-test with p<0.01, b: W-M Rank Sum test with p<0.01. 
45 
ADAMS: 
As illustrated in Fig 2.4，significantly higher transcriptional level is observed in 
the control (Day 50 vs day 24) and the neonatal hypothyroid rats at advanced ages 
(Day 60 and 90 vs day 24 and day 30). Control rats have higher transcription levels 
than the neonatal hypothyroid rats from day 24 to 50. 
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Fig 2.4 Developmental transcription profile of ADAMS gene. Numbers on top of 
the columns show statistical significance between the data pairs by Dunn's test with 
p<0.05. Paired alphabets show statistical significance by pair comparison, a: Rank 




As shown in Fig 2.5, the transcription of ADAM6 is very similar with ADAM 4. 
Results of two-way ANOVA after square root transformation show that age, treatment 
and their interaction significantly affected the transcription of this gene (pO.OOl). 
Older rats use to have higher transcription levels than the younger rats. This is true for 
both control rats (Day 50 & 90 vs 24 & 30) and the neonatal hypothyroid rats (Day 90 
vs 24, 30 and 40). Control rats have higher transcription levels of this gene than the 
neonatal hypothyroid rats at both day 40 and day 50. 
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Fig 2.5 Developmental transcription profile of ADAM6 gene. Numbers on top of 
the columns show statistical significance between the data pairs by Dunn's test with 
p<0.05. Paired alphabets show statistical significance by pair comparisons, a: 
Unpaired-test with p<0.01. b: Rank Sum test with p<0.01. 
47 
XDAM15: 
As illustrated in Fig 2.6，only a significant age effect on the transcription of 
ADAM 15 is profound (Results of 2-way ANOVA after loglO transformation: 
pO.OOl). A gradual drop of its transcription in the developing rat testis is illustrated. 
Higher transcription levels are usually observed in the younger animals. 
A D A M 1 5 





(D 100 - I •� i , 
! 门 丨 L J t i k a ^ 
O 8 0 - • ’ . “ ‘ 。 , , “ -
J) …： 
① ~ 







. 之 I 1 3 e； 
f O ：••'•- ‘ 斗 
, V j. . ~ p 
① .：::':、 : • - T 
20- … ..� r ~ ' ~ I T 
•、':•;:•、 • • • .. •叫，... .....‘..：... ...；：.V-： 
"-.•:y、，：.… ？..’.-. • • >> , ‘ . . • - V •；. 
•+:‘... a-' • • 一 . ‘ ' . » •• . . . ‘ 
n ’、. • • • “ . -
U I 1 “ ‘ 1 “ “ T ~ ^ 
24 30 40 50 60 90 
Age (Day) 
Fig 2.6 Developmental transcription profile of ADAM15 gene. Numbers on top 
of the columns show statistical significance between the data pairs by Dunn's test 
after ANOVA by Rank with all p<0.05. 
48 
XDAM15: 
As shown in Fig 2.7, maturation of the transcription of this gene in the rat testis 
is some how earlier than other genes in this study. All the factors examined with 
two-way ANOVA after logio transformation: p<0.001. In the neonatal hypothyroid 
rats, rats at day 60 have higher transcription levels than those at day 24 and 30. 
Significant higher transcription levels are also observed in the control rats than in the 




• • 1 Cont ro l 
60 - • P T U 丁 1.2 丁 
囊 5� b I•丄 T A "“ 
II I 
i： lUII 
qI _1’a _ , 1 _ I _ I _ L 
24 30 40 50 60 90 
Age (Day) 
Fig 2.7 Developmental transcription profile of ADAM18 gene. Numbers on top 
of the columns show statistical significance between the data pairs by Dunn's test 
with p<0.05. Paired alphabets show statistical significance by pair comparison, a, b: 
Rank Sum test with p<0.01. c: Unpaired t-test with p<0.001. 
49 
XDAM15: 
As shown in Fig 2.8, transcription of ADAM 30 gene is similar to those of 
ADAM2 gene. Results of two-way ANOVA after square root transformation show 
that age, treatment and their interaction significantly affected the transcription of this 
gene (p<0.001). Recovery of transcription of this gene in the neonatal hypothyroid 
rats is observed at day 50. Transcription of this gene is higher in the advanced ages in 
both control (Day 40, 50，60 vs 24) and the neonatal hypothyroid rats (Day 60 vs 24 
& 30). 
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Fig 2.8 Developmental transcription profile of ADAM30 gene. Numbers on top 
of the columns show statistical significance between the data pairs by Dunn's test 
with p<0.05. Paired alphabets show statistical significance by pair comparison, a, b: 
Unpaired t-test with p<0.05 and p<0.001 respectively. 
50 
XDAM15: 
Very similar to the transcription profiling of ADAM30, all the factors examined 
with two-way ANOVA after log 10 transformation are highly significant at the level of 
pO.OOl as shown in Fig 2.9. Control rats at day 40 have significant higher 
transcription levels those at day 24. Significant higher transcription levels are also 
observed in the neonatal hypothyroid rats at day 60 and 90 than those at day 24 and 
30. Significant higher transcription levels are also observed in the control rats than in 
the neonatal hypothyroid rats at day 24 and 30 as well as at day 40. 
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Fig 2.9 Developmental transcription profile of ADAM32 gene. Numbers on top 
of the columns show statistical significance between the data pairs by Dunn's test 
with p<0.05. Paired alphabets show statistical significance by pair comparison, a, b: 
Rank Sum test with both p<O.Ol. c: Unpaired t-test with p<0.001. 
51 
ADAMTS-1: 
As illustrated in Fig 2.10, only a significant age effect is found in the 
transcription of this gene (two-way ANOVA after log 10 transformation: p<0.001). 
Multiple comparisons with Dunn's test after ANOVA by Ranks reveal significant 




卜 T 丄 
I M i i 
1 2 0 - 1 i - l l i ^ ^ I 
I T 丨 J l t M l L 
100 - -
o ~ ~ 
U) 丁 
CO 
^ 80 - 2 Q. 
LU ~ 
岂 60 - n n T 
① 
O r - ^ 
① 
40 - J 
碧 1,2 
Q： T 
20 - ~ ^ 
0 1 1 1 1— 1 r— 
24 30 40 50 60 90 
Age (Day) 
Fig 2.10 Developmental transcription profile of ADAMTS-1 gene. Numbers on 
top of the columns show statistical significance between the data pairs by Dunn's test 
with p<0.05. Paired alphabets show statistical significance by pair comparison, a, b: 
Rank Sum test with both p<0.01. c: Unpaired Student's t-test with p<0.001. 
52 
ADAMTS-1: 
As illustrated in Fig 2.11，the pattern of transcription of ADAMTS-4 gene is 
similar to ADAMTS-1 gene. Only an age effect is significant (Results of two-way 
ANOVA after logio transformation: pO.Ol). Multiple comparisons with Dunn's test 
reveal a significant difference between the day 60 and 90 rats. 
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Age (Day) Fig 2.11 Developmental transcription profile of ADAMTS-4 gene. Number on top of the columns show statistical significance between the data pairs by Dunn's testa ter ANOVA by Rank wi h p<0.05. 
53 
ADAMTS-1: 
Significant age (pO.OOl) and treatment (p<0.01) effects are found in the 
transcription of ADAMTS-5 gene (Two-way ANOVA) as shown in Fig 2.12. A 
progressive decrease of its transcription is evidenced with significant higher 
transcription levels at day 24 than those of day 50 and 90 control rats. Significant 
higher transcription levels of the neonatal hypothyroid rats is only found at day 40. 
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Fig 2.12 Developmental transcription profile of ADAMTS-5 gene. Numbers on 
top of the columns show statistical significance between the data pairs by Dunn's test 
with p<0.05. Paired alphabets show statistical significance by pair comparisons, a: 
Unpaired t-test with p<0.05. 
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ADAMTS-16: 
From Fig 2.13, the transcription of ADAMTS-16 is different to the patterns 
mentioned earlier in this study. Effect of age, treatment and their interaction are all 
significantly affecting of this gene (Two-way ANOVA after logio transformation: 
p<0.001). Comparisons with Dunn's test reveal significant higher transcription levels 
in day 50 vs day 24 and 30 as well as day 90 vs day 30 control rats. Transcription of 
this gene in neonatal hypothyroid rats at day 90 is significantly higher than at day 40. 
Control rats have higher transcription than the experimental rats at day 40. At day 24， 
transcription of this gene is significant higher in the experimental than the control 
animals, while the opposite is true at day 50. 
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Fig 2.13 Developmental transcription profile of ADAMTS-16 gene. Numbers on 
top of columns show statistical significance between the data pairs by Dunn's test 
with p<0.05. Paired alphabets show statistical significance by pair comparisons, a: 
Rank Sum test with pO.Ol, b: Unpaired t-test with p<0.001. 
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MT3-MMP: 
Expression of MT3-MMP (as shown in Fig 2.14) is similar with the other genes 
described before. Age, treatment and their interactions were significantly varied 
(p<0.001). Lowered expression is detected before day 30 when compared with that of 
the aged. Pair-wise comparison revealed significant down-regulation of gene suffered 
by hypothyroidism was appeared at day 40 to 50. 
MT3-MMP 
400 n Control 
1 [ = • PTU 
1,4 
① 
^ 3 0 0 -
.1 I I • 
Uj 2 0 0 - • 
• 
I I jL i j 
2 4 3 0 4 0 5 0 6 0 9 0 
Age (Day) 
Fig 2.14 Developmental transcription profile of Membrane Type-3 Matrix 
Metalloprotease (MT3-MMP) gene. Numbers on top of the columns show statistical 
significance between the data pairs by Dunn's test with p<0.05. Paired alphabets "a" 
show statistical significance by unpaired Student's t-test with p<0.05. 
56 
XCE: 
As illustrated in Fig 2.15, the expression of ACE is similar with some of the 
ADAMs. Significant age, treatment and interactions were observed by 2-way ANOVA 
after logio transformation (p<0.001). Expression of ACE before adult is extremely low, 
thus a significant higher transcription was illustrated when comparing between Day 
90 verses that from Day 24 to 40 by Dunn's test. Pair-wise comparisons revealed 
distinct down-regulation for hypothyroid rats from age Day 30 to 50, while this 
returned to normal on Day 60. 
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Fig 2.15 Developmental transcription profile of Angiotensin Converting Enzyme 
(ACE) gene. Numbers on top of the columns show statistical significance between 
the data pairs by Dunn's test with p<0.05. Paired alphabets a,b，c show statistical 
significance by Rank Sum test with p<0.05, <0.01 and <0.01 respectively. 
57 
Nep: 
The expression profile of Nep, which is shown in Fig 2.16, is extremely similar 
with that of ACE. Age, treatment and their interactions were significantly affected by 
2-way ANOVA after log 10 transformation. Expression of Nep is also extremely low at 
early ages, thus drastic differences were found when comparing the expression at 
Day24 normal rats with that from Day 40 to 90. Hence distinct pair-wise 









C • • 
CO _ _ _ 
I I it 
• • 丁 
I l i l l l l 
2 4 3 0 4 0 5 0 6 0 9 0 
Age (Day) 
Fig 2.16 Developmental transcription profile of Neprilysin (Nep) gene. Numbers 
on top of the columns show statistical significance between the data pairs by Dunn's 
test with p<0.05. Paired alphabets a, b, c show statistical significance by Rank Sum 
test with p<0.05, <0.01 and <0.01 respectively. 
58 
PRSS21: 
As shown in Fig 2.17，expression Profile of PRSS21 is similar with ADAM2, 3 
and 5. Age, treatment and interactions were all significantly affected (Result of 2-way 
ANOVA with log 10 transformation, pO.OOl). Again, older rats have a significant 
higher expression of PRSS21 than young rats. Pair-wise comparisons revealed 
significant down-regulation of genes between Day 30 to 40, but also in Day 60. 
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Fig 2.17 Developmental transcription profile of PRSS21 gene. Numbers on top of 
the columns show statistical significance between the data pairs by Dunn's test with 
p<0.05. Paired alphabets show statistical significance by pair comparisons, a: Rank 




As illustrated in Fig 2.18, only a significant age effect (pO.OOl) is found after 
Log 10 transformation followed by 2-way ANOVA analysis. A gradual drop in tPA 
transcription was clearly seen. Dunn's rank sum test revealed a significant decrease 
from Day 24 vs Day 50, 60 and 90. 
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Fig 2.18 Developmental transcription profile of tissue Plasminogen Activator 
(tPA) gene. Numbers on top of the columns show statistical significance between the 





Expression of TIMP-1 is age, treatment and interaction dependent (with p<0.001, 
<0.01 and <0.05 respectively) as shown in Fig 2.19. Transcription of both control and 
hypothyroid rats is quite constant, only a lowered expression at Day 90 was detected. 
Pair-wise Students' t-test only showed a significant down-regulation at Day 30 in 
PTU-treated rats. 
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Fig 2.19 Developmental transcription profile of Tissue Inhibitor of 
MetalIoprotease-1 (TIMP-1) gene. Numbers on top of the columns show statistical 
significance between the data pairs by Dunn's test with p<0.05. Paired alphabets "a" 
shows statistical significance by Unpaired Student's t-test with p<0.01. 
61 
TlMP-2: 
Expression of TIMP-2 only showed a moderate age dependency (p<0.01), which 
is shown in Fig 2.20. No treatment or interaction variation can be observed. But a 
significant down-regulation of TIMP-2 is shown under hypothyroidism at Day 30. 
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Fig 2.20 Developmental transcription profile of Tissue Inhibitor of 




As shown in Fig 2.21, TIMP-3 only showed an age-dependent effect after Logio 
transformation (p<0.001). Dunn's multiple comparison showed a significantly 
lowered transcription at Day 40, when compared with that of early ages, suggesting a 
tread of age-dependent down-regulation. No significant pair-wise differences when 
comparing the expression between normal and hypothyroid rats at any ages. 
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Fig 2.21 Developmental transcription profile of Tissue Inhibitor of 
Metalloprotease-3 (TIMP-3) gene. Numbers on top of the columns show statistical 
significance between the data pairs by Dunn's test with p<0.05. 
63 
TIMP-4: 
As illustrated in Fig 2.22, TIMP-4 was the only TIMP family member that 
showed the characteristic expression profile like the pervious mentioned candidates. 
After square-root transformation, transcription of TIMP-4 is highly age, treatment or 
interaction dependent (p<0.001). Expressions at early ages (either in control or 
hypothyroid rats) are lowered at early ages. Pair-wise comparisons revealed 
significant drop in expression in TIMP-4 between Day 40 to 50 when pups suffered 
hypothyroidism 
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Fig 2.22 Developmental transcription profile of Tissue Inhibitor of 
Metalloprotease-4 (TIMP-4) gene. Numbers on top of the columns show statistical 
significance between the data pairs by Dunn's test with p<0.05. Paired alphabets show 
statistical significance by pair comparisons, a: Unpaired t-test with p<0.01, b: 
Rank-Sum test with pO.OOl. 
64 
«2MG: 
As illustrated in Fig 2.23, effects of age, treatment and their interactions 
significantly affected the transcription of a2MG gene (results of 2-way ANOVA 
p<0.01). Multiple comparisons with Dunn's test revealed no significant differences 
between any interesting data pairs. Only a significant higher transcription of this gene 
is found at day 30. 
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Fig 2.23 Developmental transcription profile of alpha-2 macroglobulin (aiMG) 
gene, a: Result of unpaired Student's t-test: with p<0.01. 
65 
Gystatin TE-1: 
As shown in Fig 2.24, significant age, treatment and interaction effect was 
illustrated after Logio transformation followed by 2-way AVOVA with all p-value 
lower than 0.001. A graduate increase in transcription is observed, where expression 
of Cystatin 8 at Day 30 is significantly lower than that of the aged day 40 to 90 rats by 
Dunn's test. Pair comparison also revealed significant down-regulation of hypothyroid 
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Fig 2.24 Developmental transcription profile of Cystatin 8 gene. Numbers on top 
of the columns show statistical significance between the data pairs by Dunn's test 
with p<0.05. Paired alphabets show statistical significance by pair comparisons, a: 
Rank Sum test with p<0.01, b: Unpaired Student's t-test with p<0.01. 
66 
Gystatin TE-1: 
As illustrated in Fig 2.25, expression profile of Cystatin C is different with that 
of its family Cystatin 8. Again, expression of Cystatin C is dependent on age, 
treatment and its interaction after logio transformation with p<0.001. Dunn's test 
showed significant up-regulation of expression at Day 60 where compared with that 
from early Day 24 to Day 40 in PTU-treated rats. Pair-wise comparisons also revealed 
a considerable down-regulation of Cystatin C expression from Day 24 to 40 in the 
neonatal hypothyroid rats. 
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Fig 2.25 Developmental transcription profile of Cystatin C gene. Numbers on top 
of the columns show statistical significance between the data pairs by Dunn's test 
with p<0.05. Paired alphabets show statistical significance by pair comparisons, a, c: 
Unpaired Student's t-test with p<0.05 and <0.001 respectively, b: Non-parametric 
Rank-Sum test with p<0.01. 
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Gystatin TE-1: 
Fig 2.26 shows the expression profile of Cystatin SC. Significant age, treatment 
and interaction dependencies were illustrated in the expression, while age effect is 
more prominent one (p<0.001; p<0.05 in treatment effect). An age-dependent 
down-regulation can be clearly seen, where the transcription is significantly lowered 
in Day 90. Considerable down-regulation was suffered in hypothyroid rats between 
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Fig 2.26 Developmental transcription profile of Cystatin SC gene. Numbers on 
top of the columns show statistical significance between the data pairs by Dunn's test 
with p<0.05. Paired alphabets show statistical significance by pair comparisons, a, b: 
Unpaired t-test with both p<0.01，c: Rank-Sum test with p<0.05. 
68 
Gystatin TE-1: 
As shown in Fig 2.27, the expression of Cystatin TE-1 is distinctive to the other 
cystatins examined in this study. Significant treatment and interaction effects were 
illustrated (p<0.001), while a moderate age-dependent effect is also found (p<0.05). 
Transcription of this gene in control rats is more or less constant, but lowered 
expression is initiated in rats suffered from hypothyroidism at pre-pubertal ages. Pair • 
comparisons showed a significant down-regulation at Day 24 and 30 in the 
PTU-treated rats. 
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Fig 2.27 Developmental transcription profile of Cystatin TE-1 gene. Numbers on 
top of the columns show statistical significance between the data pairs by Dunn's test 
with p<0.05. Paired alphabets show statistical significance by pair comparisons, a: 
Rank Sum test with p<0.05, b: Unpaired Student's t-test with p<0.05. 
69 
Bikunin: 
The transcription of Bikunin, which is illustrated in Fig 2.28, is very similar to 
those of ADAM4 and ADAM6. Results of two-way ANOVA showed significant age, 
treatment and their interaction variations on their transcription with p<0.001 after 
logio transformation. Older rats seem to have a higher transcription levels than that of 
younger rats. Expression is extremely low before Day 30, but a rapid boost in 
transcription was seen at Day 40 and maintained at peak afterwards. Significant “ 
down-regulation of Bikunin was observed in hypothyroid pups between Day 40 and 
Day 50, where transcription restored to normal at Day 60. 
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Fig 2.28 Developmental transcription profile of Bikunin gene. Numbers on top of 
the columns show statistical significance between the data pairs by Dunn's test with 




Expression profile of PCI is unique within this study as shown in Fig 2.29. Age, 
treatment and interactions were significantly affected (p<0.001). Transcriptions of 
PCI in the neonatal hypothyroid rats are extremely low at Day 24 to Day 30. Thus 
significant elevated expression can be seen from Day 24 to day 30 verses that of Day 
40 to Day 50. Drastic down-regulation can be seen in hypothyroid rats from Day 24 to 
30 when compared with normal, but expression recovered as soon as at Day 40. 
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Fig 2.29 Developmental transcription profile of Protein C Inhibitor (PCI) gene. 
Numbers on top of the columns show statistical significance between the data pairs by 
Dunn's test with p<0.05. Paired alphabets "a" shows statistical significance by 
Rank-Sum test with p<0.01. 
71 
Clgn: 
Very similar to the ADAM 2 gene, transcription of Clgn gene is high 
significantly affected by age, treatment and their interaction from 2-way ANOVA after 
square root transformation with pO.OOl (Fig 2.30). Multiple comparisons with 
Dunn's test reveal significantly higher transcription of Clgn in day 40 control rat than 
those at day 24. Between the neonatal hypothyroid rats at day 24 and day 50, 60 and 
those between day 30 and 50, 60, significantly higher transcription of this gene is 
indicated in the older rats. At day 40，significantly higher transcription of Clgn is still 
indicated in the control. Using pair comparison, significantly higher transcription 
level is observed at day 24 and day 30. 
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Fig 2.30 Developmental transcription profile of Calmegrin (Clgn) gene, a: 
Unpaired Student's t-test with p<0.01, b: Mann-Whitney's Rank Sum test with p<0.05, 




A significant age-dependent down-regulation is clearly illustrated in Fig 2.31 
with p<0.001. Moderate treatment and interaction effect are also observed with 
p<0.05 and <0.01 respectively. High expression during early ages revealed significant 
difference when compared with that at day 60 to 90 by multiple comparisons. 
Pair-wise comparisons revealed significant differences between normal and 
hypothyroid groups at day 40 and 50. 
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Fig 2.31 Developmental transcription profile of Claudin-1 gene. Numbers on top 
of the columns show statistical significance between the data pairs by Dunn's test 
with p<0.05. Paired alphabets show statistical significance by pair comparisons. a,b: 




As illustrated in Fig 2.32，transcription of Cdh-8 is entirely unique from other 
genes being exanimate. Significant age, treatment and interaction effect was seen 
(p<0.001) by two-way ANOVA after Logio transformation, but the effect of treatment 
is less prominent (p<0.01). Both control and PTU-treated rats possess a drastic 
down-regulation when the rat grows up. Unpaired Students' t-test revealed significant 
up-regulation in Cdh8 transcription under neonatal hypothyroidism before their 
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Fig 2.32 Developmental transcription profile of Cadherin-8 (Cdh-8) gene. 
Numbers on top of the columns show statistical significance between the data pairs by 
Dunn's test with p<0.05. Paired alphabets show statistical significance by pair 




As shown in Fig 2.33, the expression profile of syndecan-4 is similar with that of 
tPA. Only a significant age-dependent down-regulation can be observed (p<0.001). 
Dunn's multiple comparisons revealed significant reduction of syndecan-4 expression 
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Fig 2.33 Developmental transcription profile of Syndecan-4 gene. Numbers on 




Significant age, treatment and interaction variations were illustrated in Fig 2.34 
by two-way ANOVA after square-root transformation. (Treatment and interaction 
effect contributes with p<0.001, while age effect was p<0.01). Expression of Sycpl in 
control remains more or less constant, but significantly lowered expressions were 
found from day 24 to 30 when compared with the plateau. Pair-wise comparisons 
revealed moderate depression in gene transcription from Day 24 to Day 30. 
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Fig 2.34 Developmental transcription profile of Synaptonemai Complex Protein 
1 (Sycpl) gene. Numbers on top of the columns show statistical significance between 
the data pairs by Dunn's test with p<0.05. Paired alphabets "a" show statistical 
significance by unpaired Student's t-test with p<0.01. 
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T R a l : 
Transcription of TRal gene is significantly affected by both age and treatment 
(p<0.001; results of 2-way ANOVA after Logio transformation) but not their 
interaction. Multiple comparisons after ANOVA by rank using Dunn's test indicate 
significant higher levels of transcription of TRal in the neonatal hypothyroid rat testis 
at day 24, 30, 40 than at day 90. Due to the large variations of the transcription of this 
gene at day 24 and 30, only a significant higher transcription of thyroid hormone 
receptor is found at day 40. 
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Fig 2.35 Developmental transcription profile of Thyroid Hormone Receptor a l 
subunit (TRal) gene. Numbers on top of the columns show statistical significance 
between the data pairs by Dunn's test with p<0.05. Paired alphabets "a" show 
statistical significance by unpaired Student's t-test with p<0.01. 
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Screening Data 
In order to facilitate the study of transcription profiling in an economical way, a 
screening method was adopted to reduce the sample numbers in PCRs with certain 
representations to the final pictures of the profiling. Sample cDNAs collected within 
same age and treatment group were pooled together to make up a library. Twelve 
libraries made of six age groups (at day 24，30, 40, 50 60 and 90) and two treatment 
groups (Control and PTU-induced hypothyroidism) were subjected to Real-Time PGR „ 
j 
with replicates as previously described. This approach of using the screening idea can 
retain the accuracy and representation of the transcription profiling, since the overall 
pattern from this screening is highly symmetry with that of the standard method as 
mentioned before (Fig 3.0). I hope the results of these screening tests can shed certain 
light on understanding the complicated control mechanisms in spermatogenesis. 
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Fig 3.0 Gene expression profiling using the standard method and the screening 
method. The overall transcription pattern is not deviated much between these two 
approaches. This suggests the screening test is useful to provide an over-view on the 
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Fig 3.1 Screening transcription profiles of some transcription modulators. 
GATA4 and Id-2 are mainly expressed in spermatogonia. Act and Zfp37 are 
predominantly expressed in post-meiotic spermatids. Pki (3 is "meiotic", while the 




cdc42 Ras GRP-1 
2 0 1 18-
1 8 - 1.6 - > 
1： 11 n 卜 n r 
m k i y i L 
24 3 0 35 4 0 45 50 60 90 24 30 35 40 45 SO 6 0 90 
Age (Day) Age (Day) 
Rhes RhO A 
2 .5 1 2 ,0 . 
门 1 9 -
I n I n n 
1 n 1… 门 
S 1 5 - S 1 2 -
？ • n f j . . 
. • 1—1 . • • 
^ i l I M i m l 丨 : 1 M M 1 L 
24 30 35 40 45 50 60 90 24 30 35 40 4S 50 60 90 
Age (Day) Age (Day) 
Nedd4a NT3 
I B 1 350 
• f ~ I , 300 -
> ^ 250 • 
i 1 2 . _ 1 
丨 U i M 丨 U I L L l 
24 30 4 0 50 8 0 90 24 30 40 SO 6 0 90 
Age Age (Day) 
Fig 3.2 Screening transcription profiles of some signal transducers and 
messengers. Expressions of small GTPase like Rho subfamily of cdc42 and RhoA 
as well as Ras GRP-1 are constant throughout age, except Rhes which have an 
age-dependent down-regulation trend. Nedd4a is classified in the "Somatic" cluster 
where its main site of expression is in CNS, but abundant amount is present in other 
tissues. NT3 has a unique profile similar with that of TRal and Cdh-8, elevated 
transcription was identified in early ages under neonatal hypothyroidism. 
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Fig 3.3 Screening transcription profiles of Pcsk4, its putative substrate 
PACAP38 and respective receptor PACAPr. Pcsk4 is known to be meiotic, while 
PACAP38 is post-meiotic. A trend of age-dependent down-regulation is shown in 
PACAPr, suggesting it may be predominantly expressed in Sertoli cells. 
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Fig 3.4 Screening transcription profiles of the two motor proteins: Dncicl and 
KPR2. KRP2 have the characteristic post-meiotic pattern, while Dncicl should be of 
multiple cell origin. 
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Eroteolysis related genes: 
ADAM10 ADAM17 
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Fig 3.5 Screening transcription profiles of some proteases. All proteases have 
multiple expression origins in testicular cell population and also abundantly expressed 
in other somatic tissue like brain and cartilage. Age-dependent down-regulation is 
possibly suggested in the expression of Calpain I，while the remaining members 
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Fig 3.6 Screening transcription profiles of some endogenous protease inhibitors. 
PAI-1 and P2MG are globally expressed in most of the testicular cells. Nexin-1 is 
critical in early sex determination and thus higher expression in younger rats is seen. 
Spink2 seems to be meiotic, while drastic down-regulation of calpastatin and Eppin 
were shown in adult rats, thus the latter two should be more likely to be post-meiotic. 
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-Junction and Matrix Molecules: 
Matrix Gla Protein (MGP) 
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Fig 3.7 Screening transcription profiles of some matrix molecules. MGP and 
Col3al are previously identified as mitotic, Sert-1 as meiotic and testin as somatic. 
Axin and Sertolin have similar pattern of temporal expression with that of testin, 
which may suggested that both of them are also widely expressed. 
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-Junction and Matrix Molecules: 
Matrix Gla Protein (MGP) 
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Fig 3.7 Screening transcription profiles of some matrix molecules. MGP and 
Col3al are previously identified as mitotic, Sert-1 as meiotic and testin as somatic. 
Axin and Sertolin have similar pattern of temporal expression with that of testin, 
which may suggested that both of them are also widely expressed. 
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-Junction and Matrix Molecules: 
Occludin Claudin-11 
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Fig 3.8 Screening transcription profiles of some testicular junction molecules. 
These six genes are representative members in unique junctions present in testis: tight 
junction, adhering junction and gap junction. Whether these genes are affected by age 
or hypothyroid treatments requires further studies, as both Sertoli and germ cells 
contribute to the total testis expression. 
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Post-meiotic Spermatids Specific genes: 
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Fig 3.9 Screening transcription profiles of some spermatid-specific genes. TPs 
and Prms are long-time regarded as markers of post-meiotic spermatids due to their 
distinctive chromosomal arrangement. Odfl is also a major constitute of sperm tail, 
while SplO and Spam are related to fertilization and membrane fusion. All of them 
possess the characteristic Post-Meiotic pattern described in current study. 
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Cell specific markers: 
p-actin Cathepsin B 
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Fig 3.10 Transcription profiles of selected marker genes. (3-actin and Cathepsin B 
has been shown to be universally expressed in all kinds of testicular cells. In our 
experiment, both of them are not age or treatment affected, thus p-actin has been used 
as housekeeping gene in my study. LDHc is a marker for meiotic germ cells and 
possess the typical meiotic pattern. 3P-hydroxysteroid dehydrogenase is specifically 
expressed in Leydig cells. Androgen binding protein (ABP) and activin PA are 
markers specifically transcribed in Sertoli cells. Elevated expression under 
hypothyroidism at early ages suggested the possibility of the presence of proliferating 
Sertoli in this period. 87 
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Expression of non-spermatogenic genes at neonatal age 
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Fig 4: Expression of selected genes under normal and hypothyroid condition 
before puberty. In this experiment, hypothyroidism was induced by adding 0.05% 
MMI in mother rats' drinking water from prenatal day 16 until scarified. Expression 
of all genes above are significantly affected by age, treatment and their interaction 
after two-way AVONA with p>0.01. Annotations above columns denotes for 
statistically higher expression by Dunn's test with different significance. ** denotes 
for p<0.01, * for p<0.05. 
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丨 
Responsiveness of gene transcription after thyroxin Replacement 
In this second set of experiment, three groups of rats were scarified at age of 
postnatal day 40 and day 50. The first group "Control" is normal rats that given with 
tap water. In second group "PTU", 0.1% PTU was given from day 4 to day 24 in 
mother's drinking water. In the third group "PTU + T4", a single dose of thyroxin at 
sub-physiological dose was injected at day 35 that given with same hypothyroid 
treatment as the "PTU" group. 
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Fig 5.1 Body and testis weights (per paired testes) in second set of experiment 
with T4 replacement therapy. Significant differences revealed by Dunn's test are 
shown as number pairs on top of columns. 
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Sbdy and testis weights 
In this set of experiment, comparable results can be found in control and PTU 
groups as before as shown in Fig 5.2. T4 replacement cannot restore body, absolute 
and relative testis weight changes by the neonatal hypothyroidism at both day 40 and 
50. 
ADAM2: 
As shown in Fig 5.2, the expression of ADAM2 under hypothyroidism is similar 
with that of the previously descript (Fig 2.1). Significant down-regulation can be 
observed at Day 40 under neonatal hypothyroidism (p<0.01), while transcription is 
indifferent with that of normal at Day 50. Single dose of T4 replacement at day 35 is 
ineffective to restore the lowered transcription levels to PTU treatment at day 40. 
ADAM3: 
As illustrated in Fig 5.3, the expression of ADAM3 under hypothyroidism is 
similar with previous descriptions (Fig 2.2). Significant down-regulation can be 
observed at Day 40 under neonatal hypothyroidism (p<0.05), while transcription is 
indifferent with that of normal at Day 50. Due to large variation in T4 replacement 
group, only a trend of transcription recovery (p<0.19) was found at day 40. 
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ADAM4: 
The responsiveness of T4 replacement of ADAM4 is shown in Fig 5.4. Previous 
experiment showed ADAM4 suffered a prolonged down-regulation under neonatal 
hypothyroidism (Fig 2.3) when compared with ADAM2, 3 and 5. (Fig 2.1, 2.2 and 2.4 
respectively). Again, expression of ADAM4 in PTU-treated rats is significantly 
lowered than that of control at both day 40 and 50 in this study (p<0.01 and <0.001 
respectively). T4 replacement is able to rescue the decreased expression levels at day 
40 to certain extent but not back to the normal level (p<0.14). At day 50, both PTU 
and T4 replacement groups are significantly decreased (pO.OOl) when compared to 
the control rats. 
ADAMS: 
As shown in Fig 5.5, a severe down-regulation of ADAMS is observed at both 
day 40 and day 50 as before (Fig 2.4). Unlike ADAM2, T4 replacement restores target 
gene transcription to normal level at day 40, but not at day 50. Number above 
columns revealed statistical significance by Dunn's test after two-way ANOVA 
analysis with p<0.05 
ADAM6: 
Similar with that of ADAM4, a comparable down-regulation pattern is also 
observed in case of ADAM 6 which is illustrated in Fig 5.6. Significantly lowered 
transcriptions are observed at both day 40 to 50 (p<0.01 and <0.001 respectively). 
Sharing the similarities with that of ADAM 4，T4 replacement is only effective to 
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recover the lowered expression to certain extent bur not significantly back to normal 
at day 40 (p<0.136). At day 50’ same result of ADAM4 is achieved. 
ADAM18: 
As shown in Fig 5.7, a severe down-regulation of ADAM 18 is observed at day 
40 (p<0.001) but not at day 50 as before (Fig 2.7). Again due to the large variation of 
T4 replacement group, only a trend of recovery (p<0.06) can be seen at day 40, but no 
statistical difference can be found at day 50. 
Pcsk4: 
Transcriptions of Pcsk 4 in this study are similar to the results of ADAMS. With 
decreased expression upon hypothyroid treatment (p<0.05 at both age), T4 
replacement is able to restore the transcription of this gene back to normal at day 40 
(p<0.05) but not at day 50. 
PRSS21: 
Another putative protease, PRSS21, have shown similar responsiveness (Fig 5.9) 
with that of ADAM2 (Fig 5.2). Hypothyroid-induced down-regulation was previously 
shown (Fig 2.17) to be effective only before day 40 (p<0.05), and expression 
recovered after day 50. Same observations can be seen in this set of experiment, and 
also revealed that T4 replacement recover the lowered transcription due to PTU 
treatment at day 40 (p<0.05). However, this recovery is not extended up to day 50. 
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ADAMTS-16: 
Just like the transcriptions of ADAM4 (Fig 5.4) and ADAM6 (Fig 5.6), 
significant down-regulation was observed under hypothyroidism even until day 50 
(pO.OOl), which is demonstrated in Fig 5.10. The administration of single dose of T4 
is able to rescue the transcription levels to a higher but not back to the normal levels 
at Day 40 (p<0.632). At day 50, both PTU and T4 replacement group are significantly 
lowered in their expression of ADAMTS-16 when compared to their control group 
(pO.OOl). 
TIMP-4: 
Similar trends can be observed in protease inhibitors like TIMP-4 (Fig 5.11). 
Hypothyroid rats suffer from significant down-regulation at day 40 and day 50 
(p<0.05). Thyroxin replacement was able to restore certain degree of transcription 
reduction due to hypothyroidism (p<0.38 when compared with control), but not in day 
50 (p<0.05 when compared with control). 
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Fig 5.3 Response of ADAM3 gene expression at day 40 and 50 under T4 
replacement. 
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Fig 5.4 Response of ADAM4 gene expression at day 40 and 50 under T4 
replacement. 
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Fig 5.5 Response of ADAMS gene expression at day 40 and 50 under T4 
replacement. 
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Fig 5.6 Response of ADAM6 gene expression at day 40 and 50 under T4 
replacement. 
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Fig 5.7 Response of ADAM 18 gene expression at day 40 and 50 under T4 
replacement. 
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Fig 5.8 Response of Proprotein convertase subtilisin/kexin type 4 (Pcsk4) gene 
expression at day 40 and 50 under T4 replacement. 
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Fig 5.9 Response of PRSS21 gene expression at day 40 and 50 under T4 
replacement. 
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Fig 5.11 Response of TIMP-4 gene expression at day 40 and 50 under T4 
replacement. 
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� C h a n g e s of gene expression under different hypothyroid regimens 
In the third set of experiment, different induction regimens of experimental 
hypothyroidism were used to investigate their effects on various targeted genes 
expression in rats scarified at day 50. Annotations of the X-axis are labelled as 
follows: P4-24 represent the group of rats that given with 0.1% PTU from postnatal 
day 4 to 24. M pi7-26 stands for the group that start the 0.05% MMI from prenatal i 
day 17 to postnatal day 26. M 4-24 correspond to the pups that given 0.05% MMI I 
from postnatal day 4 to 24. P4-16 denotes the cluster given with 0.1% PTU from j 
postpartum day 4 to 16 only. Finally ML 4-24 is the rats that were given 0.0125% | 
"i 







The change in body weight under regimens of hypothyroidism is demonstrated in 
Fig 6.1. Except the group that was given with lowered MMI concentration, all other 
treatment of hypothyroidism caused significant decrease in body weight at the levels 
of p<0.001. Shortening the period of PTU administration by 8 days returns total body 
weights of rats significantly (pO.OOl). The group of 0.0125% MMI group is not 
suffered from decreased body weight when compared with other treatments (p<0.01) 
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Fig 6.1 Alternations in body weight under different induction regimens of 
hypothyroidism. Number pairs on each column represent statistical differences 
revealed by Dunn's test after one-way ANOVA with p<0.05. 
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Absolute testicular weight: 
The change in absolute testicular weight is summarized in Fig 6.2. When 
comparing testis weights of rats, the first three groups of treated rats cannot restore 
their testis weight loss (p<0.001), while the groups that benefits from shortened PTU 
administration and lowed MMI concentration have comparable testis size with that of 
normal. Ending the PTU treatment at day 16 can recover most of the testis weight loss 
when compared with that ends at day 24 (p<0.01). Pups with prolonged MMI 
administration before birth suffered a further decrease in absolute testis weight than 
with postnatal treatment only (p<0.05). Again, pups with 0.0125% MMI 
! 
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Fig 6.2 Alternations of absolute testicular weight (per paired testes) under 
different induction regimens of hypothyroidism. Number pairs on each column 
represent statistical differences revealed by Dunn's test after one-way ANOVA. 
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"•Relative testicular weight: 
Interesting findings are found in term of relative testis weights in this study 
which is illustrated in Fig 6.3. All treatment groups except the one with extended 
hypothyroid period have significant larger relative testes weights. However, this 
increase in relative testicular size is more or less at the same levels, no significances 
were found among these groups. Number pairs on each column represent statistical 
differences revealed by Dunn's test after one-way ANOVA with p<0.05. 
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Fig 6.3 Alternations of relative testicular weight (per paired testes) under 
different induction regimens of hypothyroidism. Number pairs on each column 
represent statistical differences revealed by Dunn's test after one-way ANOVA with 
p<0.05. 
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ADAM2 and ADAMS: 
As summerized in Fig 6.4, a significant downregulation of both genes can be 
identified at 0.1% PTU as demonstrated before (Fig 2.1 and 2.4 respectively. 
Significant reduction of transcription can also be observed at groups with MMI 
treatment under the prolonged and standard duration of hypothyroid induction. ). No 
significant down-regulations were seen in groups that neither treated with shortened 
period nor lowered concentration of MMI. 
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Fig 6.4 Transcriptions of ADAM2 and ADAMS genes under different neonatal 
hypothyroid regimens. All number pairs on each column revealed statistical 
differences with p<0.05 by Dunn's test. 
101 
ADAM6 and ADAMTS-16: 
As illustrated in Fig 6.5, severe down-regulation can be observed in all 
treatments except the one fed with lower MMI concentration. Major down-regulations 
are observed under normal PTU and prolonged MMI treatment (pO.OOl)，with a less 
severe decrease in the other two groups. 
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Bikunin and TIMP-4: 
As demonstrated in Fig 6.6, these two endogenous protease inhibitors have 
similar expression pattern under different induction regimen. Again, significant down 
regulations were seen on the first three groups that applied with more intense 
hypothyroid induction, while the two groups that have milder treatments are not 
affected. 
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Fig 6.6 Transcriptions of Bikunin and TIMP-4 under different neonatal 
hypothyroid regimens. Number pairs revealed statistical differences with p<0.05 by 
Dunn's test. 
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i3RP2 and Pcsk4: 
As shown in Fig 6.7, expressions were decreased significantly and equally under 
PTU and MMI administration for normal and extended period, while shortened or 
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Fig 6.7 Transcriptions of KRP2 and Pcsk4 genes under different hypothyroid 
regimens. All number pairs on each column revealed statistical differences with 
p<0.05 by Dunn's test. 
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Pkip and GATA-4: 
In contrast with the previous genes, the mitotic Pkip and GATA-4 display a 
completely different picture to the hypothyroid responses as shown in Fig 6.8. 
Expression of both genes is similar in all treatment groups except the one given with 
low MMI concentration. The latter case brings up a significant up regulation when 
compared with the other four groups including the control. The group that applied 
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Fig 6.8 Transcriptions of Pkip and GATA-4 genes under different hypothyroid 
regimens. Number pairs revealed statistical differences with p<0.05 by Dunn's test. 
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Odfl andTPl: 
Expressions of spermatid-specific genes are quite unique in this study as 
demonstrated in Fig 6.9. All treatments suffered from different degrees of 
down-regulation of Odfl and TPl under hypothyroidism. The degree of 
down-regulation depends on the intensity of goitrogen treatment, where the effect on 
two less intensive groups is relatively smaller. 
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Fig 6.9 Transcriptions of Odfl and TPl genes under different hypothyroid 
regimens. Number pairs revealed statistical differences with p<0.05 by Dunn's test. 
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‘ Discussion: 
The pattern of body weight suppression in this neonatal hypothyroid treatment is 
similar to previous reports using same regimen. A rapid catch-up growth is seen soon 
after the cessation of rats under PTU treatment, but their body growth eventually 
paralleled with that of controls at day 90 but never caught up (Fig 1.1). A constant 
20% decrease in overall body weight is always suffered by hypothyroidism, which is 
similar with other studies. However, the increase in testis weight is not parallel with 
that of body weight. A drastic 75% reduction of testis was seen during and 
immediately after PTU treatment. But after subsequent return back to euthyroid state, 
testis weight recovers in a more prominent manner, which eventually having a 
significantly larger testis than that of the controls at day 90 onwards (Fig 1.2). The use 
of relative testicular weight as parameter for reproductive ability revealed even more 
interesting figure. The testis weight preserved 50% of its mass immediately after PTU 
treatment, but the catch-up growth is rapid that a significantly bigger relative 
testicular weight is found at Day 50 (Fig 1.3). This increase seems becoming even 
more prominent as the rat ages. PTU administration affects the growth of rats in an 
overall ratio, as similar proportion of reductions in size and weight were seen in other 
organs. Thus the use of relative testicular weight is a more comprehensive parameter 
to reflect the fertility of male rats. 
Five patterns of transcription profile: 
Using neonatal hypothyroidism as a model of studying the transcription profile 
during testicular hypertrophy, I can identify and characterize my results into 5 
107 
dtfferent groups according to their temporal expression from puberty to matured 
adults: 
pt pattern: 
Transcription of this family of genes is almost undetectable before Day 24 for 
both control and hypothyroid groups. Starting from Day 30，expression of these genes 
within control group gradually increases until Day 50, when the transcription reaches 
the peak and plateau off at later ages. But in hypothyroid group, a lag of about 10-day 
in expression trend is observed. The transcription of these genes starts around Day 40 
in PTU-treated rats, and continues to increase until Day 60 and reaches plateau. Thus 
a significant down-regulation of these genes was observed around Day 30 to Day 40 
in the treated pups. Examples of genes that fall into this group are ADAM2, 3, 5, 18, 
30, 32, PRSS21, Clgn, Cystain C and the marker of meiotic cells Lactate 
Dehydrogenase 3 C-chain (LDHc). 
2nd pattern: 
The expression pattern is similar with that of first pattern, with only a ten-day 
delay shift in the entire profile. Transcription of this family of gene is very low 
at/before Day 30. At post partum Day 40, expression started to rise and rapidly 
plateau of at Day 50. Hypothyroid group still suffered from that 10-day lag, with 
expression appeared as late as Day 50. Significant down-regulation was observed 
between Day 40 to Day 50 in PTU-treated rats. Example of genes that belongs to this 
category is ADAM4, ADAM 6，ACE, Nep, Cystatin 8, Bikunin and all post-meiotic 
spermatids markers like transition proteins (TPl and 2) and protamine 2 (Prm2). 
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pattern: 
No significant age, treatment or interaction variation was seen after the two-way 
ANOVA analysis. Expression of these genes is not age-dependent. Neonatal 
hypothyroidism seems not suffer any lag in overall expression trend, thus no 
significant down-regulation was examined in all age groups after pair-wise 
comparisons. Genes like ADAM 10 and ADAM 17, uPA, a2MG, P2MG, TIMP2, 
Nedd4a and most cathepsins belong to this group. 
4th pattern: 
This group of genes is already highly expressed in testis as soon as Day 24, and 
rapidly peaked at Day 30 of the pre-pubertal stage. Expression at later stages remains 
constant. Hypothyroidism also suffers a 10-day lag within this family. Expression is 
extremely low before Day 30, but quickly climbed back to normal at Day 40. PCI, 
Cystatin SC and TE-1, Dncic 1 and MGP have this form of expression profile. 
5th pattern: 
Transcription of these genes was maximum before puberty, but suffers from a 
gradual decrease of expression when the rats age. This age-dependent down 
regulation is continuous until Day 90, when minimal is found. AD AMI 5, 
ADAMTS-1/4/5, Syndecan-4, tPA, TRal , Claudin-1 and Cdh-8 etc have this 
expression profile. 
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� This data of using neonatal hypothyroidism as model of studying fertility shares 
extreme coherence with a recent large scale micro-array expression profiling 
analysis84. ！口 that experiment, four particular types of testicular cells: Sertoli cells, 
spermatogonia, pachytene spermatocytes and early spermatids were isolated with their 
expression of 11,955 chosen loci was investigated. Among the 1268 loci that display 
differential expression, they were organized into four main clusters according to their 
dominant expression localization: Somatic, mitotic, meiotic and post-meiotic 
respectively. Interestingly, all investigated genes that were clustered into same 
classification have identical expression trends that we have described. For example, 
ADAM2, ADAM3, and ADAMS, which suffered from down-regulation between Day 
30 to Day 40，were all clustered as "MEIOTIC", while genes like ADAM 4 and 
ADAM 6, which shown similar down-regulation between Day 40 to Day 50, were all 
clustered as "POST-MEIOTIC". Most genes that have neither shown age nor 
hypothyroid dependencies in our experiments were clustered as "SOMATIC". This 
important finding may help us to guess the predominant location of expression for 
some other un-clustered genes, if this hypothesis of linkage is a real one. 
Genes With known clustering information; 
Meiotic Post-Meiotic Mitotic Somatic 
A D A M 2, 3, 5 ADAM4, 6, PACAP38, GATA-4, Id-2 ADAM 10, 17 
Pkip, Spam, SplO, KRP2 TIMP-1,-3 a^MG, p.MG 
Sert-1, Prm2, TP1，TP2 Col3al Testin, Nedd4a 
LDHc Cystatin 8，Pcsk4 MGP TIMP-2 
Table 2: Summary of studied genes that with identified clustering information. 
Data are kindly provided by Dr. Ulrich Schlecht of Biozentrum, and Swiss Institute of 
Bioinformatics, Basel, Switzerland. Please refer to GermOnline at 
http://www. biozentrum. iinibas. ch/personal/primig/rat一spermatogenesis/ for most 
updated information in related subject. 
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^ggest ion on the role of "MEIOTIC" proteases and inhibitors 
This classification of proteases and protease inhibitors may also shed light on 
explaining their role of matrix remodelling during each stage of spermatogenesis. The 
establishment of tight junction is completed around Day 15 in rats^^ thus here I 
assume that the start of normal spermatogenesis at this age. Although the appearance 
of spermatocytes can be as early as Day 12, these cells will be eliminated without the 
protection of Blood-Testis Barrier (BTB). Undifferentiated type B spermatogonia 
normally take two weeks to become the first member of primary spermatocytes, the 
leptotene cells. During this stage, leptotene cells were arrested to wait for the 
transversion across the intermediate compartment of Sertoli cells. This implicates that 
before postpartum Day 30, leptotene cells need to secrete proteins that requires for 
continuous disassembly and assembly of tight junction protein. Notice that the 
expression of "MEIOTIC" proteases and protease inhibitors appears around Day 30, 
which evoke that "MEIOTIC" proteases maybe required for the digestion of tight 
junction protein, while "MEIOTIC" protease inhibitors are essential to maintain the 
integrity of blood-testis barrier at non-specific sites by suppressing the proteolysis. 
I l l 
_ „ Postnatal day of 
Cell type ！ 
. ‘ first appearance 
As Spermatogonia 4-6 
Undifferentiated 
Apr Spermatogonia 4-6 
spermatogonia 
Aai Spermatogonia 4-6 
Ai.4 Spermatogonia 4-6 
Differentiating 
In Spermatogonia 6 
spermatogonia 
B Spermatogonia 6 
Pre-Leptotene 9-12 
Meiosis I Leptotene 9-12 
Primary Zygotene 15-18 
Spermatocytes Pachytene 15-18 
Diplotene 23-26 
Meiosis II Secondary Spermatocytes 26 
Round Spermatids 26 
Post-meiotic 
Condensing Spermatids 38 
Spermiognensis 
Spermatozoa 45 
Table 3: Timing for first time appearance of male germ cell line lineage in rats. 
Morphological data based on morphological study from Clermont and Perey4 carried 
out five decades before and is one of the classical studies in the related field. Table 
modified from McCarrey . 
Genes that has been classified as "Meiotic" in our study are ADAM 2, 3’ 5, 
Proprotein convertase subtilisin/ kexin type 4 (Pcsk 4), Sertoli cell protein 1 (Sert-1) 
and Protein kinase inhibitor beta (Pki (3). Peaked expression of these genes in meiotic 
spermatocytes suggested that they are critical candidates in monitoring the process of 
meiosis. These genes may be involved in the cytoplasmic reformation from diploid 
spermatids to haploid spermatids. Trans-version across the tight junction also take 
place before maturation of spermatocytes, thus meiotic genes may responsible for 
maintaining the integrity of Sertoli cell barrier through refining the synthesis of 
proteases and its inhibitors. 
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Suggestion on the role of "POST-MEIOTIC" proteases and inhibitors: 
If this hypothesis is true, I can continue this story as following: assuming 
successful spermatogenesis starts after the establishment of BTB at Day 15. After 
synthesizing "MEIOTIC" proteases and protease inhibitors, spermatocytes goes on 
differentiation to become matured spermatids, which normally takes around 14 more 
days. Therefore around postpartum Day 40，matured spermatids are developed and 
readily to be released from Sertoli cells. In order to hold the developed sperm 
avoiding the premature release, substances like protease inhibitor may necessary for 
reinforcing the apical ectoplasmic specialization. After completion of maturation, 
spermatids secrete another type of substances that digest the adhesive molecules for 
spermiation. Again, the expressions of "POST-MEIOTIC" proteases were not initiated 
before Day 40, which proposed that "POST-MEIOTIC" proteases may be responsible 
for the digestion of these Sertoli-germ cell junction complexes just before spermiation. 
Also, these genes may also be a component in the functional aspect of matured sperm, 
for example acrosomal proteins that facilitate the fertilization during sperm-egg 
membrane fusion or embryo implantation. 
Genes that were catalogued as "Post-meiotic" are ADAM 4, 6, TPl, TP2 and 
Prm2, Sperm Protein 10 (SplO, which is also called ACRVl, acrosomal vesicle 
protein 1), Sperm adhesion molecule (Spam), and Outer dense fiber of sperm tail 1 
(Odfl). Notice that most of these genes are markers of mature spermatids that assist 
fertilization through sperm-egg binding or translocation, thus "Post-meiotic" 
proteases should be responsible for spermiation or fertilization process, while protease 
inhibitors should be in charge of inhibiting the activation of acrosomal proteases or 
reinforcing the ectoplasmic specialization. 
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Explanations on "SOMATIC，’ genes: 
Previous studies proposed that testicular hypertrophy induced by neonatal 
hypothyroidism is due to the increased number of Sertoli cells; potentially increase 
the available number of sperm that can be supported. Unlike FSH, thyroid hormone 
cannot Hi rectiy stimulate the mitosis of both Sertoli cells and germ cells, meaning that 
hypothyroidism can only slow down the maturation of Sertoli cells, thus prolonging 
the proliferative period for replenishment. From my data on "SOMATIC" gene 
transcription profiles, most of them showed no specific age or treatment dependencies. 
"Somatic" genes are referred to genes that are mainly expressed in Sertoli cells in 
testis, but also presents in other somatic tissue like brain and bone. Hence somatic 
genes are genes that are widely expressed, and sometimes noticeable amount of 
transcript is present even in spermatogenic germ cells. Due to the large diversity of 
expression in varies tissues; these genes should be responsible for some universal 
functions that are required by most cells, for example signal transduction or 
housekeeping, i heir role on direct matrix remodelling is less emphasised. Genes that 
were grouped as "Somatic" are Cathepsin-L and B, tPA, ADAM 10 and 17，global 
protease inhibitor asMG and beta-2 Microglobulin (P2MG), TIMP-2, cell junction 
proteins like testin, and Neural precursor cell expressed, developmentally 
down-regulated gene 4a (Nedd4a). 
The development of Sertoli cells is entirely in the neonatal period, which is much 
earlier than that of our experimental design which begins at Day 24. Thus extending 
the temporal study starting from Day 4 may be helpful in understanding the 
participation of "SOMATIC" genes. It is known that neonatal treatment of PTU 
starting at Day 8 is unresponsive in increasing the testis mass and daily sperm 
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production in adult，which proposed that the critical period of thyroid hormones on 
Sertoli cells may be limited to a period before Day 8. So the transcription of 
"SOMATIC" genes should be studied at neonatal ages, otherwise the pattern will be 
similar with those in our experiment, which already plateau off for both control and 
hypothyroid at Day 24. 
Explainations on "MITOTIC，，genes: 
This investigation over several "mitotic" genes failed to identify a specific 
clear-cut expression pattern as reported in previous mentioned model. For example, in 
the case of TIMP-1 and Matrix Gla Protein (MGP), they show down-regulation 
during early stages of PTU-treated pups and recover to normal levels after Day 40. 
But from my preliminary screening data over families of small GTPases like RhoA, 
cdc42 and Rhes and transcription factors GATA4, gene expressions seem to show 
some trends of up-regulation during the pubertal stage of hypothyroid rats. Moreover, 
genes like Id-2 and GATA-4 have clear trend of age-dependent down-regulation 
during the development. Therefore genes that are classified as "mitotic" may not need 
to share a homogenous expression profile within the group. It is known that mitosis in 
spermatogonia can be either "Proliferative" (for self-renewal) or "Differentating" (for 
gamete production), thus identification of genes that regulate these two individual 
stages may requires more refined isolation method. Histological isolation of 
proliferative and differentiating spermatogonia before clustering study can give clues 
in suggesting the role of these genes during the mitosis. 
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Explanations on the un-clustered pattern: 
This type of genes showed an exceptional high transcription at the pre-pubertal 
age of Day 24. Although the expression is peaked at early ages, neonatal hypothyroid 
state still affects the expression of these genes before Day 30. Many members within 
this family was investigated but not being clustered, meaning that they do not display 
specific differential expression over any particular testicular cell types. These genes 
may participate in a more general or common purposes that shares similarities 
between Sertoli cells and germ cells, for example activation of cytokines or receptors, 
or being a candidate in universal signal transduction or cytoskeletal reformation 
during the development. These genes also suffered a severe down-regulation due to 
the hypothyroid treatment from day 24 to 30. If the 10-day lag is still applicable, the 
critical functional period of these genes under normal condition should be around Day 
15, which is the terminal period of which Sertoli cells cease dividing. These genes 
may be the true contributors in deferring the cessation of Sertoli cells' proliferative 
period, and genes involved maybe expressed in multiple types of testicular cells but 
not only in Sertoli cells. 
Explanations on the age dependent down-regulation group: 
Most of these genes encode secretory product that are produced by Sertoli cells. 
Significant age-dependent decrease of overall expression suggested that these genes 
are responsible for testicular development before puberty, i.e. Sertoli cell maturation 
and tight junction formation. Decreased transcriptions over the age suggest that these 
candidates may not be the main participants in spermatogenesis. Another reason for 
this down-regulation may be due to changes in the proportion of testicular cells. 
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Relative proportion of different cell populations within testis 
• Haploid 
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Fig 7. Relative proportions of n, 2n and 4n cells within the testis. Appearance 
of haploid spermatids can be as early as postnatal day 24, but significant proportion is 
achieved until day 30, and becoming the major constitutional cell type in testis 
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afterwards. Data are obtained from Malkov et al., 1998. 
Before puberty, major constitute of testis are diploid spermatogonia and somatic 
cells as shown in Fig 7. When the rat grows up, spermatogenesis starts over and 
increases the overall proportion of spermatocytes. Eventually in the adults, haploid 
spermatocytes and spermatids contribute to most of the cell population in testis, 
making the transcription levels in Sertoli cell to the whole testis relatively lower. 
Proposed clustering of genes according to their transcription profile: 
Clustering of some target genes in this study has already been known, but large 
proportion of them yet needs to be identified. By comparing the unique and distinct 
transcription profiles among different target genes, I am able to correlate my findings 
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on certain uncharacterized genes with those established genes to predict their 
predominant gene expression sites in the testis. 
It is known that post-meiotic spermatids are not appeared before day 30 under 
normal condition. Due to the delay in maturation, the appearance of spermatids in rats 
suffered from neonatal hypothyroidism should further be postponed for two weeks. 
Thus genes that fall into "Post-meiotic" cluster should have two characteristics: 1. 
Very low expression levels before day 30 and start to rise to plateau levels afterwards. 
2. Significant reduction in transcription of these genes in PTU-treated rats with 
expression starts to recover as late as day 60. Thus genes like calpastatin, KRP2 and 
others share similar expression pattern with known "Post-Meiotic" candidates like 
ADAM4 and ADAM6 should belong to the same cluster. This clustering idea can be 
validated by some well-known markers of specific spermatogenic cells. In this case, 
the TPs and Prms which are specific markers of post-meiotic spermatids also 
expressed in a similar pattern. 
Using similar approach, identification of genes belonging to meiotic cluster is 
carried out. When considering the markers of diploid spermatocytes, several 
characteristics of meiotic expression profile can be drawn. Very similar with those in 
"Post-meiotic" cluster, gene expressions of "meiotic" genes are extremely scarce due 
to the low abundance of spermatocytes before puberty. Soon after the initiation of 
gametogenesis, the proportion of spermatocytes begins to rise at postnatal day 30, 
which starts the appearance of "meiotic gene" transcription. Under neonatal 
hypothyroidism, a ten-day delay in maturation of Sertoli cell is resulted, making the 
appearances of these meiotic genes postponed to day 40 when a significant down 
regulation resulted. At day 50, the relative testicular weights in PTU-treated litters 
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tiave already overshot that of the normal, reflecting that the testicular environment (in 
terms of proportions of gem cell in testicular population) should be comparable, thus 
no differences in overall transcription is foreseen. It should be reminded that even the 
transcription profiles of “Meiotic” and "Post-Meiotic" cluster are highly symmetrical 
where the first time appearance in hypothyroid rats is the only discriminating factor, 
the identification of these two individual clusters must be clear-cut without confusing. 
Spermatids would not synthesize "meiotic" mRNA; the appearances of meiotic 
proteins are the translation products of internal transcript store. Yet the expression of 
"meiotic" genes is always appeared in spermatids also, the regulatory mechanism of 
transcription in these two clusters is completely different. Meiotic spermatocytes are 
mainly diploid while post-meiotic spermatids are all haploid. Unique critical period of 
expression and pre-dominant localization suggested that the putative functions of the 
two gene cluster can be overlapping but distinct from each other. 
Proposing cluster of genes by current profiling . 、：、： 
. . . . . . Meiotic : .. Post-Meiotic "2 為 
ADAM 18,30,32 ~ ADAMTS-16 
Clgn, PRSS21, MT3-MMP, tACE, 
Bikunin, Spinkl — Zfp37，PACAP38, 
Cystatin C — Nep , TIMP-4 
Calpastatin, Act, Eppin 
Table 4: Suggested spermatogenic clustering of some uncharacterized genes in 
this study. The clustering idea is based on the unique expression profiling under 
different developmental stages as described. Owning to some limitation, this 
clustering idea is only applicable to identification of spermatogenic (meiotic and 
post-meiotic) candidates. 
The prediction of “Mitotic” and "Somatic clusters" is probably impossible in the 
current study. As discussed before, mitotic germ cells are not of homogenous in origin. 
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Different types of mitotic spermatogonia i.e. proliferative or differentiating strains 
should have different genetic requirements, thus no unique profile feature can be 
clearly drawn. Moreover, peritubular and interstitial cells may also express 
mitosis-related genes for cell replenishment, making the identification of mitotic 
cluster even more difficult. In my study, mitotic gene cluster refers to genes that 
preferentially transcribed in mitogenic spermatogonia only, thus histological isolation 
before expression studied is required to outline their developmental profile. 
Sertoli cells are the main constitute of "somatic" cluster in the micro-array study. 
However, Leydig cell and other peritubular somatic cells are also transcriptionally 
active. It is therefore better not to define any unique expression profile for "Somatic" 
cluster in this experiment. In this experimental model, the mRNA is coming from the 
whole testis and thus is of multiple-cell origin. Relative proportion of Sertoli cells is 
actually decreasing with age, thus the transcription profile of Sertoli Cell-predominant 
genes should actually decreasing though their expression within cell should not be 
affected. As discussed before, critical period of Sertoli cell proliferation is entirely 
before the puberty. The expression of Sertoli cell specific genes may not be altered 
within day 24 to 90 in this study. Using these two characteristics (age dependent down 
regulation and no hypothyroid dependency), I suggest that genes like AD AMI 5, tPA, 
Cystatin SC, Syndecan-4, TRal , Calpain I would be preferentially expressed in 
Sertoli cell mainly. 
"SOMATIC" genes expressions are neither affected by age nor treatment. Since 
these candidates are widely expressed in both Sertoli and germ cells, the temporal 
expression profiles of the whole testicular tissues can not be used to identify whether 
they are Sertoli or germ cell specific. The constant and stable expression of these 
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^ n e s is not simply the summation of age-related up regulated spermatogenic portion 
and age-related down-regulated Sertoli cell portion. The transcription profiles of 
somatic genes are heavily influenced by their preference on site of expression and the 
relative proportion of cell population during that particular age. For simplicity, here I 
suggest genes that are constantly expressed without age or treatment dependency as 
"Somatic" cluster; meaning their site of expression is diverse and complicated. 
Proposing cluster of genes by current profiling 
Sertoli cell predominant Somatic (Mixed originate) 
— ADAM 15, ADAMTS-1, -4, -5 cdc42，Ras GRP-1, Rhes, Rho A, 
tPA, Cystatin SC, Claudin-1, 一 uPA, PAI-1, sACE 
Cadherin-8, Syndecan-4, TRal , Cathepsin L，B, C, MMP-9, 
Calpain I, Nexin-1, PACAPr Axin, Sertolin, Occludin, Claudin-11, 
E-/N-Cadherin, Cadherin-11, Cx43 
Table 5: Suggested non-spermatogenic clustering of some uncharacterized genes 
in this study. Profiling of these two gene clusters is much more complicated and far 
less reliable than that of the two spermatogenic clusters using the current model. This 
clustering idea requires further immuno-histological or even laser assisted 
microdissection RT-PCR investigations for confirmation of their site of expression. 
Now I want to take ACE as an example to describe my idea on gene profiling. 
The ACE gene encodes both a somatic and testicular isozymes. The former one 
(sACE) is widely expressed in many somatic cells, including endothelial and Leydig 
cells in testis. But the latter one (also named as testicular or germinal ACE, tACE) is a 
testis-specific form, which is predominantly expressed in spermatids and 
spermatozoa^^. sACE consists of both N- and C-domain, while tACE is a splice 
variant of sACE with deletion of N- that cleaved in germ cells. Although N-domain is 
responsible for ecto-domain shedding and catalytic function^^, infertility is resulted in 
knockout mice deficient in tACE but not in sACE)� . 
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““ Here I report the transcription of sACE (between somatic-specific region and 
shared sequence), tACE (the region between the testicular-specific region and the 
shared sequence) and ACE, which is a common sequence at the 3’ end of the whole 
gene. 
1730-1768 3431-3450 
sACE I .. I “ 
20 59-2041 " ^ 6 7 - 3 7 8 6 
2075-2094 
-9-46 (3431-3450 Of SACE) 
tACE 一 
413-436 1-2430 
(2041-2059 Of SACE) (3757-3785 OfsACE) 
ACE 
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Fig 8. Primers design of ACE, sACE and tACE and their respective 
transcription profiles. tACE is an truncated form of sACE, but a specific sequence is 
also present in testicular form. Based on these primer designs, transcription profiles of 
the three sequences are shown above. Both ACE and tACE share a similar expression 
with the characteristic post-meiotic pattern, while expression of sACE seems constant 
throughout age and treatment. 
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� Consistent with my prediction, spermatid-specific tACE shows the characteristic 
"post-meiotic" profile as previously described. The somatic isozyme sACE that 
widely expressed in multiple cell types also presents the typical "somatic" profile 
without age or hypothyroid dependency. Since tACE is the predominant isoform in 
the testis, with spermatogenic cells as the major portion within testicular population, 
the expression of their common transcript ACE is very similar with that of tACE. 
Expression of some non-spermatogenic genes before puberty 
In order to look for the genes that may be responsible for the extension of 
proliferation period of Sertoli cells, I extend my study by focusing to candidates of 
genes that are not germ cell specific, since germ cells do not contribute for a major 
proportion of testicular population within this critical period. It is known that the 
effect of hypothyroidism on testis hypertrophy is only effective when the 
administration of PTU is before postpartum Day 8. This suggests that thyroid 
hormones may take its stimulatory effect of maturation of Sertoli cell at the early 
perinatal period. Under normal conditions, Sertoli cells cease proliferation around 
Day 16. Temporal study on transcription of selected genes at Day 8, 16 and 24 may 
help in giving clues of understanding the mechanism of how hypothyroidism extend 
the proliferation period by slowing down the maturation of Sertoli cells. 
Hypothyroidism was induced by adding 0.05% MMI in mother rats' drinking water 
from prenatal day 16 instead, and treatment continues until pups were scarified. 
(Result on this part of experiment is attached in the Figure 4 as follows). LDHc, 
marker of meiotic germ cells, is also studied for comparison. 
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Again, no unified expression pattern can be drawn from this experiment. Result 
of LDHc validated that meiotic germ cells are present in normal rats as soon as day 24, 
but still absent in hypothyroid rats. All of the studied genes have not been affected by 
hypothyroid treatment before Day 8，suggesting that the action of thyroid hormone on 
transcription modulation is a gradual but not an immediate process. At Day 16, when 
the Sertoli cells start to cease proliferation, the expressions of cystatins, Claudin-11 
and Clgn start to rise, but the expression in PTU-treated pups remains lower at their 
basal levels. This down-regulation of cystatins due to hypothyroidism is extended up 
to Day 30. Down-regulation of Claudin-11 further validates that the delay and 
impairment of tight junctions suffered from neonatal hypothyroidism. Lowered 
expression of inhibitory cystatins may be a factor in lengthening the maturation of 
Sertoli cells, hence providing a greater capacity for cell division. In contrast, the 
uncharacterized ADAMTS-16 and TIMP-4 is highly up regulated during the postnatal 
period with a drastic drop before entering the puberty. Since the substrate for this 
putative secretory protease ADAMTS-16 is still unknown, the paradoxically high 
expression of ADAMTS-16 together with TIMP-4 genes at neonatal period may 
responsible for the perinatal development, for example sex determination. 
Even though the molecular mechanism of testicular hypertrophy in neonatal 
hypothyroid rat is still unknown, it was proposed that cell-cycle regulators are 
possible candidates for prolonged Sertoli cell proliferation. Two cyclin-dependent 
kinase inhibitors (CDKI) and which inhibit the action of cyclin-cdk 
complex to progress through G1 checkpoint, are shown to be involved in Sertoli cell 
proliferation^'. Knockout mice lacking p21�Pi and have increased Sertoli cell 
numbers by 100% and 50% respectively*^". 
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Neonatal hypothyroidism induced testicular hypertrophy as a model for studying 
reproductive physiology 
The use of neonatal hypothyroidism as model to study male reproductive 
physiology is quite well-established. Morphological data supported the role of thyroid 
hormone on Sertoli cell maturation. The formation of tubular lumen, which is a 
marker of seminiferous tubule development and Sertoli cell differentiation, is not seen 
even until day 30 under PTU-treatment, where its appearance should be as soon as 
day 20 normally^^ Also, there is an increase in degeneration of spermatocytes and 
spermatids in pups suffered from hypothyroidism, suggesting that the establishment 
of tight junctions or other testicular environmental factors is not yet completed before 
day 30 under this neonatal hypothyroid treatment. It is now compromised that the 
increased size of testis is due to prolonged proliferation of Sertoli cell. In our 
experiment, the delay of differentiation (in terms of mRNA transcription) is at least 
ten days or more. Although the actual delay in maturation is slightly different among 
different studies, it was evidenced that mitogenically active Sertoli cells is still 
appeared in postnatal day 25 under PTU treatment^'^. This may imply that neonatal 
hypothyroidism provides a good model in studying the development and 
differentiation of testis around the puberty. 
The response of gene expressions to T4 replacement on hypothyroid rats is quite 
consistent in this study. In my second set of experiment (4.1 to 4.11), all genes with 
lowered transcription levels in the neonatal hypothyroid rats are able to restore to 
normal levels at certain extend upon replacement. A single dose of T4 at day 35 
restores the transcription of hypothyroid rats back to normal at day 40. This effect of 
replacement therapy is however not long lasting. An injection of T4 at day 35 is not 
125 
^ l e to restore the transcription of several target genes back to normal at day 50. It is 
because the dosage of T4 used in this experiment is relative low and the biological 
half life of T4 in rats is only around six days. The results of this replacement therapy 
study show us whether the examined target genes are thyroid hormone responsive or 
not. 
In order to rule out the possibility of toxic effect due to the PTU treatment, the 
third set of experiment was carried out. From the results of this experiment using 
different experimental hypothyroid induction regimens, I try to validate whether 
alternation of gene transcription in the testis depends on different levels of 
experimental hypothyroidism (Results summarized in Fig 6.1 to 6.9). At Day 50, 
when most of the post-meiotic genes were still being down-regulated in the neonatal 
hypothyroid rats, shortening of the hypothyroid period reduces the responsiveness of 
certain target genes, though a significant difference is still present when comparing 
with that of controls. Comparing relative testicular weights within various treatment 
groups, the administration of PTU from day 4 to 24 is indifferent with same treatment 
that ends at day 16. This suggests that the induction of testicular hypertrophy in the 
neonatal hypothyroid rats may be earlier than day 16. When the effect of a less potent 
goitrogen MMI at a relative lower concentration (0.01%) was examined, not much 
difference can be found between the relative testicular weights between the 0.1% PTU 
and 0.01% MMI treatment groups. This implies that the degree of hypothyroid need 
not be a strong one to induce significant testicular hypertrophy. Same conclusion can 
be drawn in case of using MMI at the dosage of 0.0125%. Although the increase in 
relative testicular weight is quite stable among different treatments, expression of 
genes does not change in a completely symmetric way. In this experiment, all the five 
treatments can induce a significant increase of relative testis weight at day 50, but the 
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transcription of target genes under these cases is quite paradoxical. In most of the 
post-meiotic genes, no significant changes are found in groups that have milder 
hypothyroid treatment, but a drastic down-regulation is still present for pups that were 
given 0.1% PTU, 0.01% MMI or prolonged 0.01% MMI ad libitum. Why these high 
deviations in target gene transcriptions under different treatment regimen induce the 
similar levels of testicular hypertrophy is still not known. When I look into the 
transcriptions of mitotic or meiotic genes, no differences can be identified under 
different treatment regimens. This may suggest that post-meiotic genes may not be so 
critical for the development of testicular hypertrophy in this animal model. 
Different components of spermatogenesis: 
The development and assembly of sperms is a very complex biological event. 
Spherical diploid spermatogonia undergo multi-mitosis and eventually transform to 
bigger spermatocytes with genetic materials halved. Finally the haploid spermatids 
are remodelled into a characteristic shape with intense cytoplasmic reduction and 
flapping tail. In order to identify candidates that participate in this complex 
spermatogenesis, I emphasize on genes that are specifically or primarily expressed in 
testis only. Meiosis is solely restricted in spermatogenic cells, during which chromatin 
condensation, matching and separation are important landmarks. Hence nuclear 
division related proteins that are specifically expressed in testis only are though to be 
responsible for assisting meiosis. To drive the strong transcription preference over 
different type of cells, spermatogenic cells bear their own system of transcription 
control. Following the supervision from specific transcription factors, signal 
transduction molecules are essential for the subsequent protein trafficking and 
activation. Since remodelling of testicular microenvironment is the main concern, 
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dtfferent families of proteases and protease inhibitors, with their potential target: 
Junction and Matrix proteins were investigated. Developing spermatogenetic cells 
need to transverse across the seminiferous epithelium, thus a cytoplasmic motor that 
ensure the polarity of migration is required. In this section, I discuss the role of 
meiosis-related genes, transcription factors, signal transduction molecules, proteases 
and their inhibitors, junctional and matrix molecules together with motor proteins for 
their involvements in different aspects of male gametogenesis. 
I. Roles of nuclear and chromatin related genes in assisting meiosis: 
Meiosis is a prolonged nuclear division that allows sufficient time for a single 
diploid germ cell to double its DNA content, than halved twice to form 4 identical 
haploid. Pre-leptotene spermatocytes first synthesize DNA, while chromosome 
uncoiled and naked as separate chromatins. The homologous chromatins pair by 
forming synaptonemai complex in zygotene cell. After the genetic recombination of 
crossing over，chromatins start to separate and coiled with histories again to become 
chromosomes. Here I report the expression profile of Sycpl (Fig 2.34), the major 
component of Synaptonemai complex protein, where its expression can be found in 
both meiotic spermatocytes (predominant) and post-meiotic spermatids (abundant). 
Expression of Sycpl is already relative high at Day 24，when spermatid is still not 
present. This means that gene transcriptions at Day 24 are mainly taken place in 
spermatocytes or in somatic cells. This is followed by the appearance of round 
spermatids at day 30. High expression of various target genes after Day 30 is 
contributed by both meiotic and post-meiotic cell types. Expression profiling of Sycpl 
is to demonstrate the pattern of transcription of genes that co-expressed in more than 
one type of testicular cells. Another family of chromatin-related genes are the TPs and 
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Prms. During the spermiogenesis, spermatid has its own system of chromosome 
condensation that is distinctive from normal somatic histories. Within these 
post-meiotic germ cells, histories were replaced by another small basic TPs and Prms 
for DNA binding and coiling9). Unlike synaptonemal complex proteins, all TPs and 
Prms are only expressed in signal cell types, making them an ideal marker for 
identification and isolation. These genes that have unique expression preferences 
show a completely different pattern with the previous one. Take TPl and TP2 for 
examples, since their expressions are solely on spermatids^^, no transcription could be 
found until Day 40, while plateau expression afterwards is taken place in post-meiotic 
cells. 
II. Roles of specific Transcription Regulators in assisting gene selection: 
Because of the uniqueness of gametogenesis, gene expressions in meiotic 
spermatocytes are largely different with somatic cells, especially the chauvinist genes. 
These genes are transcribed only in spermatogenesis cells with a defined 
developmental d e p e n d e n c y Chauvinist genes may be responsible for carrying out 
machineries that are independent from normal somatic cells, for example sperm 
assembly, meiosis or specialized junction architecture. In order to limit and select 
gene expression that can be utilized by specific cell types, testis has their distinctive 
transcriptional control mechanism. This specialized selection, either by expressing 
testis-specific genes or splicing of specific isoforms, is thought to be an evolutionary 
advance that can provide a more suitable microenvironment for reproductive gamete 
production which other somatic tissue absent. One of the most established testis 
specific transcription regulation is the cAMP-response element modulators (CREM). 
CREM encodes a bZIP protein that binds to cAMP-response element in the promoter 
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region. CREM consists of several splicing variants, surprising that most splice 
isoforms are repressive due to the removal of the activation exon. CREM transcription 
machinery can thus be regulated by its splicing process or upon activation by 
phosphorylation of other protein kinases, or expression of other proteins like 
cAMP-response binding protein (CREB) and Activator of cAMP-responsive element 
modulator in Testis in testis (Act). Apart from CREMs, the GATA family is also a 
marker transcription factor in the testis. Especially GATA4 is shown to be regulated 
bv different endocrine factors like testosterone and Sertoli cell paracrines or 
autocrines in the testis. Yet another transcriptional regulators that also influenced by 
endocrine system is the Inhibition of Differentiation proteins (Ids), which suppress 
transcription of differentiation related genes by forming dimmers against bHLH 
motifs in the TATA-box. 
Preliminary screening data of transcription modulators are summarized in Fig 3.1 
of the Appendix. Diploid spermatogonia, haploid spermatocytes and spermatids 
together with somatic testicular cells are all transcriptionally active, thus at least 3 
kinds of control mechanisms can be foreseen. GATA-4 卯 and Id-2 99 are 
predominantly expressed in spermatogonia and showing the typical "mitotic" pattern, 
while Act'oo and Zfp37'°' which are mainly expressed on spermatids also revealed 
the characteristic "post-meiotic" profile. Expression of is thought to be 
more universal, multiple origin of expression is suggested. is also a key 
regulator of transcription in germ cells together with CREM showed the typical 
"meiotic" profile. 
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Iti. Role of Signal Transduction molecules for protein translation and activation: 
For proper expression and functioning of proteins, signal transduction cascades 
are essential for carrying a great variety of purposes, for example post-translational 
structural modification, functional regulatory machineries through phosphorylation or 
adenylation, protein trafficking and intracellular communications. Unlike the 
specialized transcription regulations previously mentioned, signalling molecules are 
always not cell-specific, and is universally appeared in other somatic cells. Protein 
kinases like PKA and PKC; cAMP, G-proteins and small GTPases may be liable for 
the regulation of junction dynamics【。斗’ since some major junction proteins like 
occludins, cadherins, catenins and integrins� have putative phosphorylation sites. It 
was also demonstrated that a transient increase in cAMP and/or cGMP was observed 
during the assembly of tight junction, but return to basal level once the construction 
completed. 
Small GTPases are involved in various cellular functions, for example regulation 
of gene expression, adhesion, cell cycle progression and apoptosis'^\ which are all 
important for development of the testis and spermatogenesis. In my investigation over 
the Rho subfamily of cdc42 and RhoA; Ras GRP-1 and Rhes, the expression of these 
small GTPase seems not dependent on age and treatment (Fig 3.2). Sertoli cells are 
their predominant expression site, while profound abundance was also detected in 
germ cells. Constantly high expression throughout life and without treatment 
dependency may implicate that these candidates are of universal housekeeping 
functions and less related in functional spermatogenesis. Neiirotrophin-3 (NT3), 
which shown to involve in testis morphogenesis'^^, has the unique transcription 
profile that similar to Cadherin-8 and TRal . 
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一 Implementation of messengers or functional proteins always requires interaction 
of other enzymes for their activation. Proprotein convertases are good example of this. 
Proprotein convertase subtilisin/kexin type 4 (Pcsk4) is a putative substrate for 
pituitary adenylate cyclase-activating polypeptide (PACAP) ac t iva t ion 'PACAPs 
are growth factors that are critical in cell proliferation and differentiat ionTogether 
with their specific receptors (PACAPr), these candidates can alter the signal 
transduction during spermatogenesis. Other kinds of putative substrates of proprotein 
convertase are the main concern in my study, the ADAMs. Most ADAMs contains a 
proprotein convertase cleavage site between their pro- and metalloprotease domains 
Cleaving of pro-domain is necessary for the proper trafficking across ER and its 
conformation folding. In the current study (data summarized in Fig 3.3), Pcsk4 and 
PACAP38 belong to meiotic and postmeiotic cluster, while PACAP receptor (PACAPr) 
should be Sertoli cell predominant by prediction. This may imply that germ cells may 
actively secrete enzymes and signals to the surrounding Sertoli cells for establishing 
spermatogenesis. 
IV. Role of proteases and inhibitors for matrix and junctions dynamics 
The high versatility of proteases and their endogenous inhibitors during 
spermatogenesis has been discussed previously according to their main expression 
sites. Apart from structural remodelling by proteolysis of ECM and junction 
components, proteases can activates cytokines to activate different signal transduction 
cascades. They can shed and activate proteins or ligand receptors to modulate 
membrane specificity and their response. Testicular proteases and their endogenous 
inhibitors can further be divided into 2 subclasses: somatic and spermatogenic: 
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The somatic proteases and inhibitors system in the testis: 
ADAMIO"® and ADAM 17川 are well known candidates of intercellular 
signalling for their sheddase activity of Notch ligands and TNFa. Gelatinase B 
( M M P - 9 ) 112，Cathepsin L"^, uPA""^ and calpain I have been reported to be 
involved in the matrix remodelling in the testis. Nex in -1 is another protease 
that inhibits other proteases like tPA, uPA and thymosins. (Transcription profiles 
of these genes are summarized in Fig 3.5 and 3.6 of the Appendix). All these are 
example of somatic proteases and inhibitors that presents in Sertoli cells. 
In case of the PA system, time-dependent down-regulation of tPA was 
observed in both control and hypothyroid rats (Fig 2.18), while the expression of 
uPA seems to be unaffected (Fig 3.5). In this experiment, PA inhibitors like PCI 
(PAI-3) was highly expressed from pubertal to adult control rats (Fig 2.29), 
which may account for the continuous degeneration of PAs throughout the time. 
Hypothyroid rats benefits from a 10-day delay in the boosting of inhibitors 
expression. This delay may provide a longer period for the action of PAs for 
matrix remodelling or cytoskeleton modification that can assist in extending the 
proliferative period of Sertoli cells. Spermatogenesis is one of the continuous 
lifetime machinery in mammalian testis. Down-regulation of tPAs throughout 
age advancement implicates that PAs may not be the main contributors of 
spermatogenesis, but play more important role in the early development of testis 
between prenatal to pubertal periods. Similar correlation was observed in the 
Calpain and Calpastatin system. Calpain I, a calcium-dependent widely 
expressed cysteine protease, is down-regulated in the aging rats. Its endogenous 
specific inhibitor, calpastatin' also suffered a 10-day delay in its expression 
133 
一 profile under the neonatal PTU treatment even if it should be 
spermatids-originated. Thus evidences are provided that the critical period of 
somatic proteases and inhibitors that regulate the junction dynamics is limited to 
the pre-pubertal period that is critical for Sertoli cell proliferation. These genes 
may be responsible for the molecular maturation of Sertoli cells or premature 
assembly of blood-testis barrier. However, proteins encoded may not be the 
essential candidates in maintaining the microenvironment for spermatogenesis or 
sperm maturation. 
Spermatogenic proteases and inhibitors system: 
Most of the studied proteases (especially ADAMs) and inhibitors that 
predominantly expressed in developing germ cells have a completely different 
picture with that of the somatic PAs. In contrast, these genes were apparently 
undetectable before puberty with a drastic rise in their transcription was observed 
just before the sexual maturation. This kind of expression profile is symmetrical 
with the reproductive period of rats. Normal male rats would not be fully sexual 
mature until Day 50. Sperms isolated from pre-mature rats are not optimal for 
fertilization. High expression level of target genes maintained in the testis of 
mature male rats suggested that these genes are responsible for the modulation of 
spermatogenesis. Dislike the cases of somatic genes, both spermatogenic 
proteases and inhibitors were expressed at high levels. Excessive production of 
the two counteracting families suggested that both candidates are required to 
sustain the process of spermatogenesis. High expression of protease inhibitors is 
required for protection of unwanted proteolysis and upkeep the rigidity of Sertoli 
cell barrier, at the same time, expression of specific proteases are essential to 
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一 remove these obstacles for maturation. 
Transcription of meiotic proteases and inhibitors are only confined in 
meiotic spermatocytes, thus their role should be related with processes like 
Sertoli-Germ cell interactions or meiosis-related machinery. In this experiment, 
expression of these meiotic genes reaches plateau at about day 40 in normal rats. 
Pups suffered from neonatal hypothyroidism have shown significant down 
regulation in their transcriptions with a ten-day delay in their expression profile. 
In case of the post-meiotic genes, expressions still maintain the plateau levels at 
day 40 in controls, while their transcriptions cannot been restored even until day 
60. This means that the post-meiotic genes may even suffer up to a twenty-day 
delay in transcription under the neonatal treatment. Post-meiotic genes are 
supposed to be involved in process of spenniogensis and fertilization. A further 
delay of ten more days of their peak expression levels indicates that the neonatal 
hypothyroidism exert an even more extensive effect in spermiogenesis. Sperms 
from neonatal goitrogen treated euthyroid adult rats are completely normal in 
terms of morphology and their fertility. It can happen that thyroid hormones are 
also involved in machineries that related in cytoplasmic remodel of spermatids. 
The expression of testicular proteases and their endogenous inhibitors are 
summarized according to their catalytic group: Serine, cysteine, aspartic and 
metalloprotease. In this experiment, plasminogen activators uPA and tPA, together 
with the uncharacterized PRSS21 are the only serine proteases being studied. 
Although widely expressed in many testicular cells, main expression site of PAs are 
Sertoli cells. Our finding in this study is that PA is down-regulated in advanced ages 
while the expression of uPA is not temporally affected. But when I look into their 
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specific serine protease inhibitors (Serpins), interesting finding showed that PAI-1 and 
PAI-3 (PCI) are also expressed in a constantly high level. Calpain I and the lysosomal 
cathepsin L and B are cysteine proteases and their expressions are also mainly on 
Sertoli cell. Most of them are assembled in pro-enzyme form, thus activation by other 
proteases may be needed. Current study indicated that cathepsins are all not affected 
by age or neonatal hypothyroid treatments and calpain I is also down-regulated in 
advanced age. Specific cysteine protease inhibitors, Cystatins, are extensively studied 
here. Although the expression profiles of Cystatin 8, C，SC and TE-1 is similar with 
those of spermatogenic members, high transcriptions are also detected at earlier ages 
in control pups, meaning that the expression site of cystatins are co-expressed in both 
somatic and spermatogenic cells. 
The characterization of testicular aspartic proteases is not that established when 
compared with the other three groups. Cathesin D and ACE are the only candidates in 
this experiment. Cathepsin D is widely expressed in Spermatocytes, Sertoli and 
Leydig cells. Expression of the two ACE isozymes, somatic and testicular forms, is 
non-overlapping. No endogenous and specific inhibitor of aspartic proteases is 
identified. But global binding globulins like a2MG and P2MG can virtually inhibit 
the activities of all proteolytic enzymes. These macroglobulins are also widely 
expressed, with Sertoli cell as their main origin. 
Metalloproteases and their inhibitors are the main focus in this study. All 
ADAMs and ADAMTSs, MMPs and the Nep belong to metalloproteases. Apparently 
most of these metalloproteases are spermatogenic origin when identified using the 
clustering idea. Most of them possess unique developmental profiles and are down 
regulated upon hypothyroidism before sexual maturation. The expression of the four 
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tissue inhibitor of metalloproteases (TIMPs) is however quite heterogeneous. TIMP-1 
and -3 are mainly expressed in spermatogonia, TIMP-2 in Sertoli cells while TIMP-4 
in spermatocytes and spermatids. The interaction of proteases and their endogenous 
inhibitors is still not very clear and substance identification would greatly help 
understanding their role on mammalian reproduction. 
V. Role of matrix and junctional molecules for intercellular interactions 
One of the limitations of proposing the role of these testicular proteases and their 
inhibitors is the lack of information on their substrate specificity. I try to correlate my 
experimental results on some of the putative substrates, especially the matrix and 
junction molecules that are essential to produce a unique microenvironment for 
gametogenesis. Apart from the structural and adhesive reinforcements, ECM can also 
serve as reservoir of cytokines and signalling molecules and serves as platform of 
signal transduction upon release by proteolysis. 
Sertolin"^, an extracellular matrix protein, is a marker of cell-cell interactions 
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that link with Sertoli cells. Testin is one of the integral anchoring proteins that 
mark the intergrity of Sertoli-germ adhering junctions, while Axin"^ is the adaptor 
that assembly and reinforce their interactions. Occludin and Claudin; Catenin and 
Cadherins as well as Cx-43 are markers of occluding tight junction, 
Sertoli-germ adhering junction and gap junction respectively. Though their 
importance in junction assembly and dynamics were already well-established, no 
significant age-dependencies of investigated genes can be observed in this study 
(Transcription profiles of above genes are highlighted in Fig 3.7 and 3.8 of the 
Appendix). Role of these junctional proteins during sexual maturation and 
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spermatogenesis still needed to be addressed. 
Collagens are one of the major constitutes that make up of the extra-cellular 
matrix. In our experiment of studying the developmental expression of Col3al, a 
tread of age-dependent down-regulation like tPA and syndecan-4 is clearly shown. 
Another adhesive protein family that presents in ECM are the syndecans. Syndecans 
are proposed to carry out its adhesive function together with ADAMs family and 
integrins. Similar with that of Col3al, a significant down-regulation of syndecan-4 is 
observed. When comparing with the expression profile with that of spermatogenic 
proteases, it is interesting to figure out that the transcriptions of these proteolytic 
enzymes are inversely proportion to that of the major components of ECMs. This may 
suggest that ADAMs present on spermatogenic cells are responsive in matrix 
remodelling during spermatogenesis through its interaction with adhesive ECM 
components. 
Although similar age-dependent down-regulation can be seen with claudin-11 
and cdh-8, most of the other junctional components were not affected. Considering 
the developmental profile of other junctional proteins, e.g. the tight junction protein 
occludin, anchoring junction protein N-/E-/P-Caherins, or gap junction protein Cx43, 
no significant trends of age or treatment dependency are evidenced. It may imply that 
all these gene candidates play an important role in the assembly of Sertoli cell 
junctions and maintenance of hardware that happens before and during 
spermatogenesis. RT-PCR data from other group using same hypothyroid treatment 
also revealed similar findings: Immunohistochemistry data revealed that these 
junctional proteins which used to be expressed onto plasma membrane surface in 
normal group were being captured within cytoplasm under hypothyroidism'^^. 
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Although the overall expression in the whole testis is not changed, but increased 
proportion of non-functional cytoplasmic junction proteins would significantly affect 
the assembly of testis dynamics. These findings may suggest that the neonatal 
hypothyroidism affect these junction proteins not by alternating their transcription 
levels, but changing the localization or trafficking of these proteins. This explanation 
can further be proven by the same morphological study, since the assembly of 
seminiferous tubule lumen is also affected under hypothyroidism. Hence alternation 
of intracellular signalling or cytoplasmic motor proteins may be responsible for the 
change in localization of these junction components. 
VI. Role of cytoplasmic motors in cellular movement 
Several theories of how the developing spermatogenie cells transverse across the 
seminiferous epithelium have been p roposed '�bu t clearly cytoplasmic motors are 
required for the developing germ cells to squeeze through crypts of Sertoli cells 
continuously. Kinesins are known molecular motors that responsible for force 
generation during variety of mobile activities within cells. The kinesin-related 
proteins (KRPs) are though to be involved in spindle dynamics during meiosis in 
particular . Dynein intermediate chain 1 (Dncicl) was proposed to be 
microtubule-based motor, in which the translocation of germ cells by ectoplasmic 
specializations is supposed to be relied on microtubule cytoskeleton'^"^. By the 
investigation on the transcription profile of these motor proteins (Fig 3.4), it is clear 
that KRP2 and Dncicl do not share similar functional responsibility. KRP2, which is 
known to be spermatid-specific, conveys motor machinery after transformation into 
haploid spermatid and Dncicl should involve in the early stages of spermatogenesis. 
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一 Conclusions: 
Proposed story of spermatogenesis - involvement of proteases and inhibitors 
Proteases like tPA and ADAMTSs are expressed extensively to build up the 
matrix architecture for the maturation of Sertoli cell and tight junction formation 
before the puberty. After the establishment of BTB, the testis is ready for the process 
of spermatogenesis to start the production of male gametes. Spermatogonia start to 
divide and differentiate into primary spermatocytes within the basal compartment. To 
prepare for the meiosis into the haploid daughters, the leptotene spermatocytes start to 
synthesis "meiotic" protease inhibitors to protect from proteolysis and retain 
blood-testis integrity together with the endogenous somatic inhibitors secreted by 
Sertoli cells. When coverage of protection is completed, "meiotic" proteases from 
spermatocytes are activated at specific contact sites on Sertoli-germ cell junction, 
opening spaces for migration across the intermediate compartment. After the 
migration into adluminal compartment, the presence of "meiotic" and "somatic" 
inhibitors stops the proteolysis and thus closes the tight junction. While spermatocytes 
continue to differentiate into spermatids, specific transcriptional controls are liable to 
activate the expression of varies spermatogenic proteins for modulating the 
cytoplasmic transformation with the support from different signalling molecules. 
During this transition, "post-meiotic" inhibitors are also synthesized to reinforce the 
adhesive junctions and ectoplasmic specialization to avoid premature release. Until 
the spermatids are fully matured and ready to be released, “post-meiotic,，proteases 
are secreted and activated to breakdown the trapping junctions for the process of 
spermiation, in addition, latent forms of these "post-meiotic" proteases can serve as 
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media for oocyte recognition and fusion. During the maturation of germ cells, Sertoli 
cells provide a fine-tuned environment by remodelling its shape and interacting 
junction. "Somatic" proteases are constantly synthesized for activation of cytokines 
and receptors that participate in signal transduction cascades to provide functional 
support over the spermatogenesis. 
Future directions: 
Many additional efforts are required to validate the role of ADAMs on the 
development of testis and process of gametogenesis. The difficulty to substantiate this 
concept is lack of information on substrates that ADAM and ADAMTS are dealing 
with. Most efforts were focused onto the two universally expressed somatic ADAMs, 
namely ADAM 10 and 17. ADAM 10 cleaves pro-TNF-a, notch and type-IV collagen, 
while ADAM 17 activates TNF-a, transforming growth factor-a and Notch. Both of 
them are important sheddases that anchored onto plasma membrane surface to 
activate signalling messengers and released their substrates from the trapping surface. 
However, the substrates that can be processed by the spermatogenic ADAMs are still 
not clear. It is also known that not every member of ADAM and ADAMTS owns 
protease activities. Bioinformatics and sequence analysis suggest that these family 
of genes share extensive homology with MMPs, in which MMPs are already 
well-established for their roles in matrix remodelling. The use of labelled zymogram 
analysis may help to understand the nature of substances that are substrates of these 
potential proteases. 
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一 Another question to understand the role of ADAMs and ADAMTSs to male 
fertility is that the cellular counterpart of the adhesive domains in these molecules is 
not known. The only well-studied case is the involvement of ADAMs 1 to 3 in 
fertilization. The ADAM 1 a/ADAM2 heterodimer together with ADAM3 are directly 
involves in the sperm penetration and zona pellucida binding through their ability of 
adhesive domains to bind with integrins from female reproductive tract and oozyte. 
Another proven candidate of ADAM members that can interact with integrin subunit 
is AD AMI 5, which have been shown to involve in interactions with matrix a9(31 
integrin in many cases like cancer and cartilage remodelling. Even though the 
composition of testis-specific ectoplasmic specialization is largely unknown at the 
molecular level, P1 integrin is though to be one of the main components within these 
j u n c t i o n s 125. ADAMs are supposed to act as a platform for shedding of biological 
active factors to support cell adhesion, while integrins are the most promising 
c a n d i d a t e s 126. Thus ADAMs may be involved in the site-directed matrix remodelling 
or membrane fusion, where the disintegrin or EGF-like domain binds to specific 
locations first; upon cleavage of pro-domain, metalloprotease domain is activated for 
other purposes of the cellular machineries. 
Localization of these genes are only predicted from micro-array data obtained by 
physical isolation of cells, extensive investigation at protein levels, for example 
immunohistochemistry and/or in situ hybridization are required to verify their 
presence at cellular level. Localization of these ADAMs in the testis can give us a 
picture on how neonatal hypothyroidism affects the assembly of testicular junctions 
and spermatogenesis. As shown previously, overall expression of genes may not be 
affected, but the trafficking and distribution of gene expression may be influenced. 
Just like the junction proteins like Cx43 or occludin, ADAMs are cell surface 
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riTolecules that only be functional when they are anchored onto the plasma membrane. 
It is known that some ADAMs are only found in meiotic spermatocytes, while the 
others are post-meiotic spermatid specific. Co-localization together with junctional 
complexes, for example tight junction or ectoplasmic specialization in specific, may 
give us some clues in proving ADAM'S ability in matrix or junction remodelling in 
the testis. ADAMTSs and many MMPs are soluble and secretory enzymes that may 
not have a specific localization. Thus knowing their cellular locations, especially on 
the spermatogenic members, may help to characterize and understand their 
involvements in spermatogenesis. Knowing more on relation of these molecules to the 
expression of Sertoli cell, Leydig cells and germ cells specific regulatory genes are 
probably helpful for us to know how neonatal hypothyroidism induced testicular 
hypertrophy in adult rats. 
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